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Aging is associated with a decline in physiological capacity and metabolic function, leading to 
increased risk for chronic conditions such as insulin resistance and diabetes.  Reduced ability to 
utilize fatty acids in the elderly has been linked to increased fat deposition within skeletal 
muscle.  However, intramuscular triglyceride (IMTG) content and its relation to substrate 
oxidation has not been clearly established in older individuals.  The two main purposes of the 
present investigation were 1.) to compare IMTG stores in the elderly with a younger group of 
men and women and 2.) to examine the relationship between substrate content and utilization 
during an acute sub-maximal bout of exercise in the elderly.  A total of thirteen sedentary, 
healthy older men (5) and women (8) aged 67 + 3 yrs were matched for gender and percent body 
fat with a younger, control group (age=39 + 6 yrs) for IMTG comparison.  Fat free mass (FFM), 
body mass index (BMI), weight, and height were not significantly different between the old and 
young and Oil Red O (ORO) staining from vastus lateralis muscle obtained by percutaneous 
needle biopsy revealed no statistically significant differences between the two groups.  Sixteen 
sedentary elderly men (5) and women (11) were given constant infusions of 13C palmitate and 
d2 glucose during 60 minutes of cycle ergometry exercise at ~58% VO2peak to assess substrate 
utilization during exercise.  There was a significant negative correlation between IMTG content 
by ORO staining and total fatty acid oxidation (rho= -0.5989; p=0.03) and IMTG content and 
oxidative capacity of muscle (rho= -0.6485; p=0.04) induced by sub-maximal exercise.  
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Oxidative capacity of muscle was not associated with rates of NPFA oxidation during sub-
maximal exercise.  Fitness was marginally correlated with fasting insulin levels (rho= -0.4857; 
p=0.056) and HOMA IR (rho= -0.4441; p=0.085).  In summary, IMTG content was not higher in 
this group of sedentary elderly compared to younger individuals, but higher IMTG content was 
associated with decreased fat oxidation during sub-maximal exercise in this group.  In addition, 
higher fitness predicted more favorable trends for markers of insulin resistance.   
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1.  Chapter One 
1.1   Introduction 
As humans age, there is a decline in physiological capacity and function, which can lead 
to increased risk for chronic disease and decreased quality of life.   Exercise may decrease or 
reverse this age-related decline.  It has been shown that both the quantity and quality of skeletal 
muscle decreases with aging. This has important implications with regard to oxidative 
metabolism in the elderly, as decreases in fatty acid metabolism have been linked to obesity and 
insulin resistance in younger adults. 
Lipids constitute a major source of energy for skeletal muscle metabolism.  Free fatty acids 
(FFA) account for a large portion of energy used during low to moderate exercise (Romijn 
1993).  The metabolism of FFA’s for use at rest or during exercise is an intricate process that 
relies on FFA release from adipose tissue (lipolysis), transport of FFA in the plasma, diffusion 
across the cell membrane, transport within the muscle cell, and subsequent oxidation within the 
mitochondria.  Perturbation of any number of these factors might alter fat oxidation. 
An inability to utilize fatty acids for energy could have deleterious metabolic 
consequences.  Reduced rates of fat metabolism have been associated with increased adiposity, 
increased insulin concentrations, and insulin resistance in middle-aged adults (Felber, Ferrannini 
et al. 1987; Zurlo, Lillioja et al. 1990; Groop, Saloranta et al. 1991; Mandarino, Consoli et al. 
1996; Kelley, Goodpaster et al. 1999; Bavenholm, Pigon et al. 2000; Horowitz 2001).     
Aging may also be associated with reduced ability to utilize fatty acids(Coggan, Spina et al. 
1992; Proctor, Sinning et al. 1995; Sial, Coggan et al. 1996).  Perhaps the increases in FM and 
reduction in muscle size and function seen in the elderly are associated with this decrease in 
oxidative metabolism.   
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Recent evidence suggests that intramuscular triglyceride (IMTG) may link impaired fatty 
acid metabolism and insulin sensitivity (Phillips, Green et al. 1996; Goodpaster, Thaete et al. 
1997; Pan, Lillioja et al. 1997).  Although it has been consistently shown that FM increases with 
age, whether IMTG stores are altered in the elderly has not been established.  Since lower 
attenuation values within skeletal muscle have been linked to increased fatty deposition within 
the muscle (Goodpaster, Kelley et al. 2000), this suggests that increased lipid content within 
skeletal muscle may be associated with poor muscle function in the elderly.  
Reduced rates of fatty acid metabolism have been linked to increased fat deposition 
within skeletal muscle (Kelley, Goodpaster et al. 1999).  Increased IMTG stores in sedentary 
individuals have been associated with obesity and insulin resistance (Goodpaster, Thaete et al. 
1997; Pan, Lillioja et al. 1997; Ebeling, Essen-Gustavsson et al. 1998; Goodpaster, Kelley et al. 
1999; Krssak, Falk Petersen et al. 1999; Manco, Mingrone et al. 2000).  Goodpaster et al 
(Goodpaster, Thaete et al. 1997) demonstrated in lean and obese individuals that increased lipid 
content in muscle by computed tomography (CT) was associated with obesity and decreased 
insulin sensitivity. 
Although higher IMTG stores in sedentary individuals are associated with obesity and 
insulin resistance, it has been reported that highly trained endurance athletes have increased 
levels of IMTG, but are also very insulin-sensitive(Goodpaster, He et al. 2001). The reasons 
behind this inconsistency are not fully understood.  However, exercise may mediate this 
increased insulin sensitivity with high IMTG content in trained individuals by repeated depletion 
and storage of triglyceride within the muscle.   
It has recently been proposed that IMTG stores are utilized to fuel working muscles 
(Phillips, Green et al. 1996), especially with exercise training (Hurley, Nemeth et al. 1986; 
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Martin, Dalsky et al. 1993; Romijn 1993).  An investigation by Hurley et al (Hurley, Nemeth et 
al. 1986) found that 12 weeks of endurance training increased caloric expenditure of fat derived 
from muscle triglyceride.  Endurance training may also provide similar benefits in the elderly.  
Therefore, studies addressing the role of IMTG stores in the elderly are warranted.   
Mechanisms by which exercise increase lipid metabolism include increases in lipolysis 
(Wahrenberg, Engfeldt et al. 1987), FFA transport across the cellular membrane (Kiens, Essen-
Gustavsson et al. 1993), increased mitochondrial enzyme capacity (Gollnick and Saltin 1982), 
and increased utilization of IMTG (Martin, Dalsky et al. 1993; Maggs, Jacob et al. 1995). 
Stable isotope infusion offers one mechanism by which fat metabolism can be indirectly 
measured (Wolfe 1998).  Lipolysis results in the hydrolysis of a triglyceride molecule into 
glycerol and 3 fatty acids.  Measures of the rate of appearance (Ra) and rate of disposal (Rd), or 
oxidation of labeled glycerol and palmitate can provide evidence of the contribution of fat 
utilized for energy at rest and during exercise.  
A number of studies have used stable isotope infusion to quantify glycerol and FFA 
release and oxidation during rest and exercise (Martin, Dalsky et al. 1993; Romijn 1993; 
Bonadonna, Groop et al. 1994; Phillips, Green et al. 1996; Sidossis 1998; Kelley, Goodpaster et 
al. 1999).  Glucose tracers are also used to allow the quantification of carbohydrate oxidation.  
Romijn et al. (Romijn 1993) utilized stable isotope methods to measure the contribution of fat 
versus carbohydrate oxidation at different exercise intensities and durations in trained cyclists.   
Substrate metabolism can also be measured by indirect calorimetry.  Indirect calorimetry 
permits quantification of fat and carbohydrate oxidation by measuring oxygen consumption and 
carbon dioxide production from expired air samples (Frayn, Lund et al. 1993).  Many studies 
have utilized this non-invasive technique to quantify fat to carbohydrate oxidation during 
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exercise.  Indirect calorimetry is especially useful in conjunction with isotope measurement to 
quantify the relative contributions of plasma and non-plasma sources of substrate oxidation. 
The decline in physical function with aging has been well documented.  Moreover, there 
are decreases in fat free mass (FFM), and oxidative metabolism (Coggan, Spina et al. 1992; 
Proctor, Sinning et al. 1995; Sial, Coggan et al. 1996; Imbeault, Prud'Homme et al. 2000; Tessari 
2000), as well as increased fat mass (Meredith, Frontera et al. 1989; Sial, Coggan et al. 1996; 
Tremblay, Drapeau et al. 1998; Tessari 2000); including fat within the muscle (Goodpaster, 
Carlson et al. 2001) with aging.  A study by Sial et al. (Sial, Coggan et al. 1996) found lower fat 
oxidation in the elderly when compared to young adults during aerobic exercise of the same 
relative or absolute exercise intensity.  Mechanisms governing this decline in muscle function are 
of great importance in the prevention or reversal of impaired muscle function in the elderly. 
Exercise could have the potential to ameliorate the decline in fat metabolism associated 
with aging, as seen in younger populations.      
1.1.1. Rationale 
It has been established that aging is associated with a decline in numerous physiological 
and metabolic parameters.  These parameters may be dictated by physiological decline 
associated with aging per sè or to the adoption of a more sedentary lifestyle in older age.   
Changes in skeletal muscle are likely implicated as the culprit in the decline of fat oxidation in 
the elderly (Seals, Hagberg et al. 1984; Coggan, Spina et al. 1992; Proctor, Sinning et al. 1995; 
Sial, Coggan et al. 1998; Schunk, Pitton et al. 1999; Imbeault, Prud'Homme et al. 2000).  It has 
been shown that increases in fat mass are associated with impaired fatty acid metabolism.  It is 
possible that increased FM with aging can lead to changes in function of muscle oxidative 
potential, leading to the decrements in fatty acid metabolism seen in the elderly. 
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Increases in IMTG stores have been associated with impaired fatty acid metabolism and 
insulin resistance (Goodpaster, Thaete et al. 1997; Goodpaster, Carlson et al. 2001; Goodpaster, 
He et al. 2001).  However, IMTG stores related to these parameters in the elderly have not been 
established.    
1.1.2. Significance 
Increased IMTG stores and reduced fatty acid metabolism are associated with risk factors 
identified in the development of metabolic diseases such as obesity and Type II diabetes.  
Identifying characteristics that are associated with these risks in elderly individuals are 
paramount to prevent or reduce the onset or severity of these conditions. 
1.1.3. Statement of the Problem 
The purpose of this investigation was to:  1) compare skeletal IMTG stores in the elderly 
and younger men and women 2) examine the association between substrate availability and 
utilization during an acute sub-maximal bout of exercise in the elderly 3) and determine if 
oxidative capacity of muscle in the elderly is associated with rates of non-plasma fatty acid 
(NPFA) utilization during exercise. 
1.1.4. Hypotheses 
It was hypothesized that: 
1.  Sedentary elderly men and women would have higher IMTG stores compared to sedentary 
younger adults of similar % body fat. 
2.  Among the elderly, higher oxidative capacity, but not IMTG stores in muscle would be 
associated with higher rates of non-plasma fatty acid (NPFA) oxidation during moderate 
intensity exercise.  
 
 15
 2.  Chapter Two 
2.1  Physiological Alterations with Aging 
Aging is associated with a decline in physiological capacity.  Declines in muscle mass, 
muscular strength, muscular endurance, VO2peak, and cardiovascular function are associated 
with increased age as well as a sedentary lifestyle (Grimby 1995; Lexell 1995; Bemben 1998; 
Tremblay, Drapeau et al. 1998; Holloszy 2000).  These declines lead to decreases in function and 
quality of life in the elderly.   
2.1.1 Body Composition and Muscle Quality Changes with Aging 
It is well documented that loss of skeletal muscle mass, or sarcopenia, occurs with aging 
(Lexell 1995; Evans 1997; Roubenoff 2000).  It has been suggested that aging results in 
approximately 15-40% decrease in muscle cross-sectional area, depending on the muscle 
measured (Aniansson, Hedberg et al. 1986; Grimby 1995; Lexell 1995; Forbes 1999; Frontera 
W. 2000; Hebuterne 2001; Landers 2001).  Decreases in skeletal muscle mass have been 
associated with muscle weakness and lower functional capacity.  In addition to decreases in 
skeletal muscle mass, increases in fat mass occur with aging.  It has been proposed that decreases 
in muscle mass lead to increased fat accumulation, which supports further muscle loss.  
According to Roubenoff (Roubenoff 2000), preliminary loss of muscle with aging results in a 
cascade of events which facilitates the further loss of muscle by 1) increasing fat mass, thereby 
2) increasing the release of cytokines known to cause insulin resistance, thereby 3) facilitating 
additional fat mass accumulation.   
A decreased percentage of FFM and an increased percentage of FM have been associated 
with functional disability in elderly women and men.  Age-related sarcopenia may be caused not 
only by reduced muscle mass or quantity, but also a reduction in muscle quality in the elderly 
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(Broadwin 2001; Goodpaster, Carlson et al. 2001).  Recent technological advancements, 
including computed tomography (CT), have allowed for more precise measurements of body 
composition (Szczepaniak 1999; Goodpaster, Thaete et al. 2000; Ross 2000; Goodpaster, 
Carlson et al. 2001) to allow not only quantitative information about fat versus fat-free mass, but 
also fat within the muscle, providing qualitative information about the muscle being studied.  
Several investigators have found increases in fat tissue accumulation in muscle of older 
individuals when compared to their younger counterparts (Rice 1989; Overend 1992; 
Goodpaster, Carlson et al. 2001) using CT.  Although promising, methodology for these 
measurement tools is still being developed.  
The importance of elucidating fat content in muscle is derived from the association of 
high fat content within skeletal muscle to a number of unfavorable conditions including insulin 
resistance, impaired fatty acid metabolism, and reduced strength (Goodpaster, Thaete et al. 1997; 
Goodpaster, Carlson et al. 2001; Goodpaster, He et al. 2001).  These body composition changes 
have major implications for the elderly with respect to disease risk and quality of life.   It is 
unclear whether these changes in muscle mass and composition are an inevitable result of the 
aging process, or are mediated by modifiable factors, such as physical activity.   
2.1.2 Muscle Structure and Function Changes with Aging 
Aging results in various skeletal muscle structural and functional changes.  In relation to 
reduced cross-sectional area of muscle found in aging muscle, decreases in the number of muscle 
fibers per unit of muscle, altered muscle fiber ratios and genetic expression, reduced muscle 
capillarization and enzyme activity, and reduced skeletal muscle oxidative capacity in aging 
skeletal muscle has been shown (Essen-Gustavsson 1986; Coggan, Spina et al. 1992; Coggan 
1993; Grimby 1995; Lexell 1995; Bemben 1998; Jozsi 2000; Kent-Braun and Ng 2000).   
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Using muscle morphology techniques from muscle biopsy samples, muscle fiber type and 
ratio, muscle lipid content, muscle capillarization and enzyme activity, and oxidative activity can 
be measured.   Muscle biopsy samples are taken primarily from the vastus lateralis of the 
quadriceps muscle, but other muscles such as the gastrocnemius or biceps brachii have been 
studied.  It is important to note that skeletal muscle fiber type and ratio varies depending on the 
muscle studied, so caution should be exercised when comparisons are made between muscle 
samples from different locations in the body (J. Keul 1972; Squire 1986).    
A study by Coggan et al. (Coggan, Spina et al. 1992) found decreased muscle fiber area 
in gastrocnemius muscle of elderly sedentary men (64+1yrs) and women (63+1yrs) when 
compared to the younger men (26+1yrs) and women (23+1yrs) studied.  Histochemical 
comparisons of the two groups studied revealed significantly smaller type IIa and type IIb fiber 
areas in the elderly group when compared to the younger group, with no differences in type I 
fiber area.  These reductions in both type II fibers reduced the type IIa/type I and type IIb/type I 
ratios for this group.  No differences in the proportions of the fibers types were seen between the 
young and old groups.   
The literature is relatively coherent with respect to fiber size reduction in the elderly.  On 
average, type II fiber size is reduced an average of 20-50%, whereas type I fibers average a 1-
25% loss (Coggan, Spina et al. 1992; Grimby 1995; Lexell 1995; Doherty 2001). Recent 
investigations measuring entire cross-sections of cadaver vastus lateralis muscle have shown, in 
addition to reduction of fiber size, an approximately 50% reduction in number of both type I and 
type II fibers of 90 year olds, when compared to 20 year olds.  These alterations in aging muscle 
lead to further declines in physiological function and quality of life in the elderly population. 
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2.1.3 Substrate Metabolism with Aging 
When compared to their younger counterparts, elderly individuals have been shown to 
exhibit lower rates of fat oxidation during exercise in several studies (Essen-Gustavsson 1986; 
Coggan 1993; Sial, Coggan et al. 1996; Kent-Braun and Ng 2000).  A study by Sial et al. (Sial, 
Coggan et al. 1996) found lower (25-35%) fat oxidation in the elderly when compared to young 
adults during aerobic exercise of the same relative or absolute exercise intensity.  In addition to 
lower fat oxidation, carbohydrate oxidation was increased in this group.  The authors attributed 
the switch in substrate metabolism seen in the elderly to age-related changes in skeletal muscle 
mitochondrial respiratory capacity.    These results are in support of other studies reporting 
similar decline (Meredith, Frontera et al. 1989; Coggan, Spina et al. 1992; Coggan, Spina et al. 
1993; Proctor, Sinning et al. 1995; Kent-Braun and Ng 2000) in muscle mitochondrial 
respiratory capacity.  The ability of older individuals to utilize IMTG is not known.  Although 
the subjects in this study were said to be physically active (although not participating in any 
organized exercise program) and matched for gender, height, weight, and lean body mass, the 
younger subjects had a significantly higher fitness level than the older subjects.   
Reduced endurance capacity in the aged is supported by reductions in oxidative capacity 
and blood flow in muscle as seen in several investigations.  Enzymatic analysis of muscle biopsy 
samples taken from sedentary older man and women (Coggan, Spina et al. 1992) revealed an 
average  25% reduction in the mitochondrial marker enzymes succinate dehydrogenase (SDH), 
citrate synthase (CS), and β-hydroxyacyl-CoA dehydrogenase.  There were a few sex differences 
in enzymatic activities of older muscle in this study.  Older women exhibited lower succinate 
dehydrogenase and citrate synthase activities than older men.  Glycolytic enzyme activity was 
not reduced in the elderly individuals in this study.  In addition, capillary density, number, and 
capillary-to-fiber ratios were also reduced in this group of older individuals when compared to 
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the younger group studied.  This investigation provides evidence that older sedentary individuals 
have reduced mitochondrial enyzyme activity and muscle capillarization. 
Animal studies substantiate decreases in endurance capacity in older versus younger rats.  A 
review by Cartee et al. (Cartee 1994) proposed that the reduction in muscle endurance seen in 
older rats due to reduced blood flow and muscle oxidative capacity is the result of increased 
reliance of glucose metabolism during exercise. 
A few studies have found no differences in skeletal muscle oxidative capacity in the elderly 
(Grimby, Danneskiold-Samsoe et al. 1982; Aniansson, Hedberg et al. 1986; Grimby 1995).  It 
has been reported that the differences seen with these investigations on Swedish elderly 
populations may be due to the lack of control of physical activity patterns (they were possibly 
quite physically active) and lack of a young control group, making comparisons difficult.   
Age-associated changes in body composition, muscle structure and function, and substrate 
metabolism have been associated with muscle weakness, reduced endurance capacity, and 
diminished quality of life in this population.  It is unknown whether the aging process itself, 
physical inactivity, or a combination of the two is responsible for these changes seen in the 
elderly.   
2.2 Muscle Fat, Obesity, and Diabetes 
Obesity and aging are risk factors for the development of type 2 diabetes.  It is well 
known that insulin has powerful effects in the regulation of free fatty acid (FFA) release from 
adipose tissue.  It is also known that obese individuals exhibit insulin resistance, particularly 
those with visceral obesity or larger quantities of adipose tissue within skeletal muscle (Pan, 
Lillioja et al. 1997; Belfiore 1998; Kelley, Goodpaster et al. 1999; Goodpaster 2000; Kelley 
2001; Kelley 2002).   
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Recent research has addressed the effects of fat accumulation in skeletal muscle in the 
development of metabolic disturbances associated with obesity and diabetes.  Kelley et al. 
(Kelley, Goodpaster et al. 1999) found that obese subjects had lower fatty acid oxidation rates 
during fasting conditions than lean subjects.  This disturbance was caused by a decreased 
oxidative enzyme capacity of skeletal muscle.  The obese individuals in this study also had lower 
attenuation values for skeletal muscle when measured by CT.  The lower attenuation values 
(low-density muscle) observed in this study were negatively correlated with the suppression of 
fat oxidation by insulin infusion.  Therefore, it appears that the fatty deposits within muscle are 
responsible, in part, for the metabolic disturbances in fatty acid metabolism seen in obesity. How 
muscle fat influences fatty acid metabolism with aging has not been studied.    
Another population with large quantities of fat within skeletal muscle is endurance 
athletes.  Although endurance athletes have high levels of intramuscular fats, they are not 
insulin-resistant.  Goodpaster et al.  (Goodpaster, He et al. 2001) found that exercise-trained 
individuals had a higher oxidative capacity of muscle, despite the high lipid content within the 
muscle when compared to sedentary lean individuals, obese individuals, or obese type 2 
diabetics.   
Therefore, the muscle’s ability to oxidize fat may be a pivotal factor in relation to the 
accumulation of lipid in muscle, obesity, insulin resistance, and the development of type 2 
diabetes.  Similar questions related to metabolic dysregulation in aging have not been addressed. 
2.3 Substrate Metabolism During Exercise  
   During exercise, the two main substrates that provide fuel for exercising muscles are fat 
and carbohydrate (CHO).  The intensity and duration of an activity, as well as the training status 
of the individual, will dictate which metabolic pathways are utilized. 
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2.3.1 Fat Oxidation 
  As mentioned previously, lipids provide a substantial source of energy during low to 
moderate exercise.  Fats in the form of stored adipose tissue or free fatty acids (FFA) are utilized 
by exercising muscles.  Several factors contribute to the utilization of fatty acids as the 
predominant energy source during exercise, which is influenced with endurance exercise training 
(Kiens, Essen-Gustavsson et al. 1993; Martin, Dalsky et al. 1993; Turner 1997; Hawley, Brouns 
et al. 1998).       
FFA oxidation has been shown to be highest with low-intensity exercise (25% -65% 
VO2max).  Research suggests that concomitant changes in FFA availability and reductions in 
long-chain fatty acid (LCFA) oxidation are responsible for the decreased reliance of FFA as a 
fuel with increasing intensity (Kanaley 1995; Sidossis, Gastaldelli et al. 1997; Hawley, Brouns et 
al. 1998; Sidossis, Wolfe et al. 1998).  LCFA depend on an enzyme-mediated transport (CPT-1) 
across the mitochondrial membrane, whereas medium-chain fatty acids can diffuse freely.  An 
investigation by Sidossis et al (Sidossis, Gastaldelli et al. 1997) examined the regulation of fatty 
acid oxidation during exercise at 40% and 80% VO2peak using isotopic tracers [1-13C] oleate 
(LCFA) and [1-14C] octanoate (MCFA). Results showed decreased oleate oxidation and 
increased octanoate oxidation during exercise at 80% VO2peak, when compared to 40% 
VO2peak, suggesting that fat oxidation was diminished due to inhibition of LCFA into the 
mitochondria.  This inhibition of LCFA into the mitochondria appears to be mediated by the 
actions of glucose and insulin (Sidossis 1996; Sidossis 1998; Sidossis, Wolfe et al. 1998).   
IMTG oxidation appears to be low during low-intensity exercise and highest with 
moderate (65% VO2peak) or high-intensity (85% VO2peak) exercise (Romijn 1993). 
 In addition to intensity, the duration of exercise has an impact on substrate utilization.  In 
another study using stable isotope tracers, a reduction in glucose release and oxidation and an 
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increase in total fat oxidation was seen with prolonged endurance training in previously active, 
but untrained males during 120 minutes of cycle ergometry at 60% VO2peak at 31 days of 
training.  The shift to fat oxidation with increasing exercise duration may also be related to 
depletion of blood glucose and glycogen stores in the muscle.   
 When measured with isotopic tracers, it is evident that although total body fat metabolism 
is increased following training, free fatty acid metabolism is actually lower.  Due to this 
discrepancy, it has been suggested that the increased fat metabolism seen with training is a result 
of oxidation of non-plasma fatty acids (NPFA), most likely in the form of IMTG (Hurley, 
Nemeth et al. 1986; Martin, Dalsky et al. 1993; Kanaley 1995; Andersson 2000).  
2.3.2 Role of IMTG 
IMTG oxidation is greater in trained individuals than untrained individuals, and appears to 
increase significantly with exercise training (Hurley, Nemeth et al. 1986; Martin, Dalsky et al. 
1993; Romijn 1993; Kanaley 1995; Sial, Coggan et al. 1998; Andersson 2000).  Martin et al. 
(Martin, Dalsky et al. 1993) found that non-plasma fatty acid (NPFA) depletion increased from 
23-47% after aerobic exercise training in previously sedentary, healthy men and women.  The 
authors speculated that the source of these NPFA was IMTG.  Another study found that fatty 
acid oxidation exceeded FFA availability during running at, above, and below the lactate 
threshold (Kanaley 1995).  Here again, the authors suggested that the additional fatty acids 
oxidized during exercise came from IMTG.   
 Although a number of studies have found depletion of IMTG stores during exercise, a 
few studies have shown no differences (Kiens, Essen-Gustavsson et al. 1993; Rico-Sanz 2000).  
One study (Kiens, Essen-Gustavsson et al. 1993) did not find depletion of IMTG during exercise, 
but found a significant decrease in IMTG during the post-exercise recovery period by muscle 
biopsy.  Trained subjects cycled at varying intensities until exhaustion (50-90% VO2peak, for an 
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average of 110 min).  Muscle biopsy samples were taken before exercise, following exercise, and 
at 3, 6, 30, and 42 hours post exercise.  No significant differences were seen immediately after 
exercise, but significant reductions in IMTG were found at 3,6, and 30 hours post exercise.  
Another study (Rico-Sanz 2000), which also employed exercise at varying intensities until 
exhaustion, found no differences in pre and post-exercise IMTG with magnetic resonance 
spectroscopy.  This study did not measure post exercise recovery period.  It is unclear why this 
discrepancy exists, but it may be due to exercise protocol.    
 Romijn et al (Romijn 1993) utilized stable isotope methods to measure the contribution 
of fat versus carbohydrate oxidation at different exercise intensities and durations in trained 
cyclists.  Tracer methods were then compared to indirect calorimetry data to derive the relative 
contribution of IMTG and glycogen stores to total fat and carbohydrate oxidation.  During low-
intensity exercise (25% VO2peak) peripheral lipolysis was high, with no further increases with 
increasing intensity, and IMTG lipolysis was low.  During exercise at 65% VO2max, IMTG 
accounted for a considerable percentage of fat utilized.  Both muscle glycogen and glucose 
oxidation increased in relation to increased exercise intensity and changes in fat metabolism 
reflected changes in CHO metabolism.    
IMTG can be measured directly by muscle biopsy, CT, MRI, or MRS; or indirectly by total 
fat oxidation measurements obtained with isotopic tracers, labeled breath samples, and indirect 
calorimetry. 
2.3.3 Carbohydrate Oxidation 
 Whereas during rest and low-intensity activities most of the fuel utilized is from fat, 
exercise at higher intensities of 70-80% VO2peak or above result in the preferential shift from fat 
to carbohydrate (CHO) oxidation (Hawley, Brouns et al. 1998).  After the first few minutes of 
exercise, glucose in the form of muscle glycogen or plasma glucose, is utilized for energy.  
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Glucose oxidation is increased with increased exercise intensity and duration (Romijn 1993).  
During prolonged exercise when muscle glycogen and blood glucose levels are depleted, the 
body can also produce glucose via gluconeogenesis.  
     As seen with fat metabolism, endurance training alters glucose utilization in muscle.  
Endurance training causes a decreased muscle glucose uptake for a given absolute workload. In 
addition, increased gluconeogenesis and increased lactate removal with training have been 
reported. 
 Substrate utilization during exercise is a complex process where the human body utilizes 
both glucose and fatty acids to supply energy to working muscles.  The energy demands for a 
particular task will dictate to what extent each metabolic pathway is used.  The specific energy 
demands of exercise in the elderly warrant further investigation. 
2.4 Conclusion
Aging is associated with reductions in physiological capacity and function.  Loss of 
muscle mass and increases in fat mass lead to a number of metabolic disturbances associated 
with obesity, insulin resistance, and impaired fatty acid metabolism.  Although information 
exists regarding muscle mass loss in the elderly, quantification of fat in muscle of the elderly has 
not been established.  In addition, little information exists regarding the role IMTG plays in 
substrate oxidation during exercise in the elderly.  Elucidating the amount of fat within muscle of 
the elderly as well as its contribution to substrate oxidation during exercise would lead to a better 
understanding of the metabolic and functional implications these factors impose on this 
population.  In addition, this information would be useful in the management of at risk 
individuals through exercise prescription.
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Physical inactivity has been associated with many chronic disease states such as obesity, 
diabetes, heart disease, osteoporosis, and certain cancers.  Physical inactivity may play a large 
role in the time of onset and continuance of the physiological declines seen with aging.  
Increasing physical activity in the elderly would be a particularly useful strategy to reduce the 
age-associated physiological and metabolic changes seen in this group. 
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 Chapter 3 
3.1   Methods 
3.1.1 Subjects 
 Sixteen sedentary men and women between the ages of 65-75 served as subjects for this 
investigation.  Subjects were recruited by flyers and newspaper ads.  Exclusion criteria for 
participation in this study are listed below.  Informed, written consent was obtained from all 
potential volunteers at the screening.  After data collection of the elderly subjects was complete, 
muscle biopsy and DEXA data from a younger, control population was obtained from a database 
of previously studied individuals for comparison with the elderly subjects. The elderly subjects 
had the same exclusionary criteria and same sampling protocol for the biopsy and DEXA as the 
younger, control group.  
3.1.2 Experimental Design 
 This study combined both an observational design (IMTG content) and a cross-sectional 
experimental design (exercise bout).  For comparison of IMTG content between the elderly and 
younger control groups, the independent variable was age group and the dependent variable was 
IMTG content.  The independent variables for the cross-sectional exercise bout in the elderly 
were IMTG content, time and intensity.  The dependent variable was fat oxidation during 
exercise.  The study design flow is depicted in Table 1.  
 
 
 
Table 1:  Study Design Flow 
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          DEXA                          Experimental Trials 
Screening      Muscle biopsy     VO2peak           Palmitate             Acetate 
                   
   ↑     1 wk     ↑      1 wk           ↑    1 wk        ↑     1 wk    ↑ 
 
 After an initial screening to determine eligibility, body composition by DEXA and a 
muscle biopsy was performed.  Each subject then completed an initial VO2max test, followed by 
the experimental trial (palmitate) and the acetate recovery trial, both of which consisted of 60 
minutes of cycling at 50% VO2 peak, as determined by the VO2peak test.  
3.1.3 Screening 
A thorough medical examination was performed at the screening visit. Exclusionary criteria 
for this study were primarily related to chronic diseases or medications which may have altered 
substrate metabolism or otherwise confounded the results of the study.  These are as followed: 
-A history of diabetes, myocardial infarction or peripheral vascular disease, proteinuria, liver 
disease, alcohol or drug abuse, malignancy or neuromuscular disease.  
-Taking chronic medications known to adversely affect glucose homeostasis (thiazide diuretics, 
oral glucocorticoids, nicotinic acid, beta blockers).  
-Gaining or losing more than 3 kg during the past 6 months. 
-A clinically positive VO2peak test revealing > 2mm ST-segment depression or evidence of CV 
compensation or a VO2peak ≥ 55 ml/kg/min fat free mass. 
-Participation in any continuous activity lasting >20 minutes more than two times per week. 
-Smoking 
-A blood pressure of > 150 mm Hg systolic, or > 95 mm Hg diastolic. 
-Screening blood laboratory results of anemia (Hct < 34%), elevated liver enzyme (25% above 
normal), proteinuria, or hypothyroidism (sTSH > 8).  
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-Findings on physical examination which include cardiac murmurs, diminished pulses or the 
presence of bruits in the lower extremities, previous history of lower extremity thrombophlebitis, 
evidence of peripheral neuropathy or muscle wasting, paresis, or edema.  
Screening laboratory evaluation included a blood count, general chemistry profile, sTSH, 
fasting lipid profile and urinalysis. In addition to medical screening, volunteers completed the 
Modifiable Activity Questionnaire (Pereira 1997) to assess current and past year physical activity 
patterns.   
After the screening visit, subjects were scheduled for an admission to the University of 
Pittsburgh GCRC to assess initial fitness level, skeletal muscle composition and FFA utilization 
during exercise.  Volunteers were scheduled for a graded exercise test at the Obesity Nutrition 
Research Center (ONRC) to assess physical fitness (VO2peak) and to determine sub-maximal 
workloads for the subsequent sub-maximal exercise trials.  After the exercise test, subjects were 
scheduled for an outpatient visit to the GCRC for a DEXA scan to measure total body 
composition and a muscle biopsy.  Approximately one week following this outpatient visit, 
volunteers were asked to perform two one-hour sub-maximal exercise bouts to assess fat 
metabolism during exercise.   
3.1.4 Physiological Determinants 
3.1.4.1 Dual Energy X-Ray Absorptiometry (DEXA):  
DEXA was performed to assess whole body composition including total body fat mass 
and fat free mass.  The DEXA divides the body into 3 compartments: lean tissue, fat tissue, and 
total body mineral.  Subjects laid on the DEXA machine, where a full-body X-ray is used to pass 
high and low photon energy levels through the tissues of the body, which is divided into a ‘grid’ 
of pixels.  The reduced energy, or attenuation, is measured as it passes through the tissue.  
Attenuation is dependent of the element composition of the tissue being measured (Gotfredsen 
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1986).  Once the values are obtained, a computer program is used to separate the body into 
compartments to obtain bone mineral, FFM, and FM for specific sites such as the arms, legs, and 
trunk. 
3.1.4.2 Muscle biopsy:   
A needle biopsy of the vastus lateralis muscle was performed using the Bergstrom 
technique (1), using suction to increase sample size (3). The typical yield is ~ 150 mg wet 
weight. This method has been utilized in prior studies (11, 12, 23), without complications in > 
500 volunteers.  This procedure was performed on an outpatient basis approximately one week 
prior to the first sub-maximal exercise bout.  Skeletal muscle lipid content was assessed by 
histochemical and biochemical methods.   
3.1.4.3 Peak Aerobic Power (VO2peak):   
Subjects performed a VO2peak test at the ONRC to determine the target work rate (50% of 
VO2peak) used for the subsequent exercise studies. This test, lasting approximately 8 to 10 min, 
was conducted using an incremental protocol on an electronically-braked cycle ergometer 
(SensorMedics Ergoline 800S). The cycle ergometry protocol consisted of a graded exercise test, 
which began at either 20 (women) or 40 (men) Watts for the first two min, and then increased 10 
to 25 Watt every two min thereafter until volitional exhaustion or one of the established criteria 
for VO2peak had been reached: an RER > 1.15, HRmax > age-predicted HRmax (220 - age), or a 
plateau in the VO2-work rate curve (Medicine 2000). Heart rate, blood pressure and ECG 
measures were recorded prior to, during and immediately following this test. Subjects breathed 
through a mouthpiece connected to a two-way breathing valve (Hans Rudolph, Kansas City, 
MO) during the test, and expired air was collected via open-circuit spirometry. Expired air was 
collected into a mixing chamber interfaced to a computerized metabolic cart (SensorMedics 
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2900) to measure expiratory flow and expired air for CO2 and O2 fractions. The metabolic cart 
analyzed and integrated signals for the determination of oxygen consumption (VO2) every 20 
seconds. None of the subjects showed any signs or symptoms of cardiovascular (CV) 
compensation, e.g. hypotensive response to exercise. These graded exercise tests were 
supervised and interpreted by a physician at the University of Pittsburgh Medical Center. 
3.1.4.4   Experimental Trials:  
 Palmitate:   
At least one week following the VO2peak test, subjects were admitted to the General 
Clinical Research Center (GCRC) the evening prior to the exercise study where they were fed a 
standard dinner consisting of 10 kcal/kg; 50% carbohydrate, 30% fat, 20% protein and then 
fasted until completion of the study. Additionally, they were instructed to avoid strenuous 
physical activity for two days prior to the study and to eat at least 200 g of carbohydrate for the 
three days preceding the study to ensure adequate glycogen stores for the exercise bout, since 
this may significantly influence substrate utilization during exercise (Karlsson 1971).  A 12-hour, 
overnight urine collection was obtained to measure nitrogen excretion rates to correct rates of 
lipid and carbohydrate oxidation for protein oxidation.  At ~ 7:00 A.M. a teflon catheter was 
placed in a forearm vein for tracer infusions.  Another catheter, used for blood sampling only, 
was placed in the dorsal hand vein of the contralateral arm in the retrograde direction, using a 
heating pad to obtain arterialized blood samples.  Palmitate trial blood and breath collection 
times are depicted in Table 2 (pg. 27).  Additional blood collection and exercise protocol details 
for the palmitate trial are provided in Appendix C (pg. 43).  Blood and breath samples were 
collected before tracer infusion for basal determination of plasma glucose, lactate, FFA, insulin, 
epinephrine, norepinephrine, glycerol, and background isotope enrichment.  Background 13CO2 
enrichment was used to calculate rates of 13C-palmitate oxidation.  After obtaining basal blood, 
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primed constant infusions of [6, 6-2H2] glucose (0.22 µmol•kg-1, 17.6 µmol•kg-1 prime) and 
[2H2] glycerol (0.1 µmol•kg-1, prime 1.5 µmol•kg-1) both 99% enriched (Isotech, Inc., 
Miamisburg, OH) were started with a calibrated syringe pump (Harvard Apparatus, Natick, MA), 
allowing 2 hours for isotopic equilibration before basal measurements of rates of glucose and 
glycerol rates of appearance (Ra) and disappearance (Rd).  After baseline measurement, blood 
samples were drawn at 105,110,115, and 120 minutes to measure basal rates of plasma glucose 
and FFA oxidation.  To determine rates of FFA Ra and Rd, a continuous infusion of 0.08 
µmol•kg-1•min-1 of [1-13C] palmitate (99% enriched, Isotech, Inc., Miamisburg, OH) bound to 
5% human albumin was begun at the onset of exercise to achieve isotopic equilibrium.  A 
priming dose of 18 µmol•kg-1 NaH13CO3 was given prior to [1-13C] palmitate infusion to 
shorten the time required to achieve equilibration of recovered expired 13CO2.  Exact infusion 
rates were calculated by measuring the concentrations of the isotopes in each infusate.  
 Exercise was initiated at ~ 9:30 A.M., and the rates of isotopic administration were 
doubled for glucose and doubled for glycerol (Wolfe 1992) to minimize changes in isotopic 
enrichment. To measure substrate utilization during exercise, subjects cycled for 60 minutes on a 
bicycle ergometer (Bosch ERG 601, Germany) at a work rate corresponding to 50% of their 
predetermined VO2peak. This was determined using the work rate-VO2 regression obtained 
during the incremental VO2peak test.  VO2 during exercise was precisely determined during the 
first 15 minutes of exercise, with work rate being monitored and either increased or decreased to 
precisely maintain 50% of VO2peak.  Thereafter, the determined work rate was held constant for 
the remaining 45 minutes of exercise.  In addition, since we had a separate heart rate (HR)-work 
rate regression from the VO2max test, HR during exercise was recorded continuously during 
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exercise with a telemetry unit and monitor (Polar, Finland) as another measure of exercise 
intensity. 
 Indirect calorimetry was performed intermittently at 0, 10, 25, 40 and 55 minutes of 
exercise to measure oxygen consumption (VO2) and carbon dioxide production (VCO2) and to 
determine rates of total lipid and carbohydrate oxidation. To obtain these measurements, subjects 
breathed through a mouthpiece connected to a two-way breathing valve at 15 minute intervals for 
a duration of 5 minutes to allow sufficient time for gas exchange equilibrium with the dead space 
in the tubing, using only the average of the last 2 minutes of VO2 and VCO2 data.  The gas 
analyzer was calibrated prior to each test. Water was provided ad libitum during exercise, and 
subjects were cooled by a fan. Blood samples were obtained in 10-ml vacutainers containing 
EDTA at 0, 15, 30, 45, and 60 minutes of exercise to determine plasma glucose, FFA, insulin, 
glycerol, and isotope enrichment.  Samples for epinephrine and norepinephrine were collected in 
iced tubes containing heparin, reduced glutathione, and ethylene glycol-bis(ß-aminoethyl ether)-
N,N,N',N'-tetraacetic acid.  Insulin is a powerful inhibitor of lipolysis, whereas catecholamines 
stimulate both lipolysis and glycogenolysis during exercise. 
Table 2:  Palmitate Trial Blood and Breath Collection Flow 
 
 
           Rest                                          ‘0’_______Exercise______________               
Baseline                (0)        105min  110min   115min  120min  15EX    30EX    45EX    60EX 
Blood Samples:   ↑       ↑      ↑      ↑        ↑      ↑       ↑      ↑            ↑ 
Breath Samples:    ↓                                ↓    ↓       ↓      ↓      ↓  
___________________________________________________________________________ 
 
  Acetate:   
Approximately one week later, the subjects came back to the GCRC to repeat the 
overnight procedure.  It has recently been proposed that measurement of breath fatty acid 
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oxidation using tracers is underestimated due to its loss into the TCA cycle.  Recent studies have 
shown that measuring acetate recovery during a separate infusion trial could correct for this loss 
(Schrauwen 1998; Schrauwen 2000).  Therefore, we measured acetate recovery during a separate 
infusion of non-radioactive 1-13 C acetate (0.08 µmol•kg-1) continued during one hour of 
exercise at 50% VO2peak (Table 3, pg.29). During this trial 1-13 C acetate was measured in plasma 
and in breath. Since glucose and glycerol were not measured, only five 5ml blood samples were 
required during this additional trial.  Additional blood collection and exercise protocol details for 
the acetate trial are provided in Appendix D (pg. 45).  
 
Table 3:  Acetate Trial Blood and Breath Collection Flow 
 
         ____Rest ___              ____________Exercise______________________               
Baseline         ‘0’    15EX    30EX    45EX    60EX 
Blood Samples:       ↑   ↑    ↑    ↑               ↑ 
Breath Samples:                ↓          ↓            ↓            ↓            ↓      
________________________________________________________________________ 
          
3.1.5 Sample Analyses   
3.1.5.1 Blood Sample Analysis 
Plasma glucose was measured with a glucose analyzer (YSI glucose analyzer, Yellow Springs, 
OH).  FFA were extracted from plasma, isolated by thin-layer chromatography, derivatized to 
their methyl esters, and measured using gas chromatography-mass spectrometry (GC-MS). 
Glycerol was analyzed from plasma samples using the glycerol kinase/glycerol phosphate 
oxidase method (Sigma Chemical Co. No. 337-UV). Plasma insulin concentrations were 
determined using a commercially available radioimmunoassay kit (Coat-A-Count, Diagnostics 
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Products Corporation) and an automated gamma counter (Wallac, Terku, Finland). Plasma 
epinephrine and norepinephrine were measured by HPLC using a reference laboratory at UPMC 
arranged through the GCRC.  HOMA IR, a marker of insulin resistance, was calculated by 
multiplying fasting glucose by fasting insulin divided by 22.5. 
Enrichment of plasma [6,6 2H] glucose was determined by GC-MS (GC, 6890 Series; 
MS, 5973N electron impact ,) analysis of the glucose pentaacetate derivatives, selectively 
monitoring ions at mass-to-charge (m/e) 200 and 202. Plasma [1-13C] palmitate enrichment was 
determined by GC-MS analysis on the methyl ester derivatives, selectively monitoring ions of 
m/e 270 and 272.  Isotopic enrichment of glycerol was measured by GC-MS, selectively 
monitoring ions of m/e 253,254, and 257.  The 13C/12C ratio in breath samples were analyzed 
by Dr. Robert Wolfe at the University of Texas Medical Branch in Galveston, TX using gas 
chromatography continuous flow isotope ratio mass spectrometry (GC-IRMS).  
3.1.5.2 Microscopy for fat content of muscle 
Neutral fat of skeletal muscle was determined on light micrographs of 8 µm-thick 
transverse cryostat sections stained with Oil Red O, using the method of Lillie (Lillie 1943). The 
Oil Red O solution was prepared as a stock solution (300 mg Oil Red O in 100 mL isopropanol 
99%).  Prior to each staining session, a working solution (12 mL Oil Red O stock + 8 mL DH2O) 
was filtered (Whatman #42; Whatman, Maidstone, UK) to remove crystallized Oil Red.  Slides 
were rinsed in DH2O for 40 seconds (2 x 20 seconds) and then rinsed for another 10 minutes 
with running tap water.  After air-drying, stained sections were covered with a cover slip using 
pure glycerol (Sigma, St Louis, MO) as an organic mounting medium, and then sealed around 
the edges of the cover slip using a butyl acetate-based acrylic polymer (Pavion, Nyack, NY) to 
prevent cover slip movement during microscopy.   Fields were examined at high power (40X), 
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using a light microscope (LEITZ) connected to a CCD camera (Sony, Tokyo, Japan), with an 
analog to digital conversion system for generation of grayscale images (Tagged image File 
Formal). Grayscale images were computer analyzed (NIH Image software) for fiber area and 
area of lipid droplets.  Oil Red staining was quantified by establishing thresholds for the intensity 
of staining using the image analysis software.  The full range of grayscale imaging was 0 to 255 
[arbitrary units (AU)], where 255 represents white, or no intensity (staining), and 0 represents 
black, or complete staining.  Staining intensities between these two extremes represent a 
continuum from white to black when converted to grayscale.  The area occupied by at least 80 
muscle fibers per subject was measured with the NIH Image software.  
3.1.6    Substrate Metabolism Measurement Techniques 
3.1.6.1    Indirect Calorimetry 
Indirect calorimetry (IC) is used to estimate rates of whole body lipid and CHO oxidation 
(energy expenditure) by measuring oxygen consumption (VO2) and carbon dioxide production 
(VCO2).  The end result of the metabolism of fat and CHO is complete oxidation into carbon 
dioxide and water. One assumption with indirect calorimetry is that all oxygen consumed to 
oxidize the substrates and all CO2 produced is recovered.  Therefore, it is possible to calculate 
total energy production.  Calculations for the oxidation of glucose and an average fat is as 
follows (Ferrannini 1988; Frayn, Lund et al. 1993): 
 
 
Glucose: 
 C6H12O6 + 6 O2 → 6 H2O + 6 CO2
For each mole of glucose oxidized, 6 mol of O2 is consumed and 6 mol of CO2 is produced.  
Therefore, the respiratory quotient (RQ), or the ratio of CO2 to O2, is 1.0. 
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 Triglyceride: 
  C55H104O6 + 78 O2 → 55 H2O + 52 CO2
 For each mole of a typical triglyceride oxidized (assumed to be palmitoyl-stearoyl-
oleoyl-glycerol) 78 mol of O2 is consumed and 55 mol of CO2 is produced. The RQ for fats is 
0.70.  The RQ for protein is 0.80.  Urinary nitrogen excretion can be used to estimate the relative 
contribution of protein metabolism to reduce error in total substrate oxidation using indirect 
calorimetry and tracers. 
 Volumes of O2 consumed and CO2 produced in glucose, fat, and protein oxidation can be 
converted to liters produced per gm or mmol of substrate oxidized.  One mole of gas (O2 or CO2) 
occupies 22.4 liters.  Calculations of rates of substrate oxidation in mmol are useful when 
indirect calorimetry is used in conjunction with tracer methodology [57].  
 O2 and CO2 gas samples are obtained by expired air collected into a mixing chamber 
interfaced to a computerized metabolic cart (SensorMedics 2900).  The metabolic cart measures 
and records the expiratory flow and expired air for CO2 and O2 fractions every 30 seconds.  
These numbers are then averaged to obtain information about substrate oxidized. 
Indirect calorimetry provides information about whole body substrate utilization, however, does 
not have the ability to distinguish the source of oxidized substrate (ie. plasma glucose or 
glycogen) or the ability to assess rates of substrate release to oxidation. 
3.1.6.2    Tracers 
Stable isotope tracers have gained recent popularity in the assessment of whole body 
substrate metabolism during exercise.  Tracers are beneficial to studying substrate metabolism 
because they allow for the measurement of substrate rate of appearance (Ra), or release and rate 
of disappearance (Rd), or oxidation.  Stable isotopes are not radioactive, and thereby safer to use.  
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By using constant infusions of labeled glucose, FFA, and glycerol tracers, it is possible to 
measure total and percentage of contribution of each substrate during rest or exercise.   
Tracers are designed to be chemically identical to the substance to be measured (tracee), 
but altered in a way that makes it distinguishable from the tracee for measurement purposes.  A 
typical stable isotope is 13C, or the stable isotope of carbon.  Whereas 12C represents the most 
abundant naturally occurring mass (98.98%) of carbon, 13C occurs with only a 1.11% frequency.  
In this fashion, identification of the tracer/tracee ratio is possible when measuring Ra and Rd 
when the small amount of naturally-occuring 13C is accounted for.  Tracers are labeled by 
numbers, which correspond to 1) their position on the molecule 2) their molecular weight, and 3) 
the number of atoms labeled on the carbon. For example, the stable FFA isotope [1-13C] 
palmitate refers to a molecule of palmitate that is labeled at the 1 position with carbon enriched 
with the stable isotope of mass 13 (Wolfe 1992).   
Since fatty acids are not water-soluble, albumin must be added to the palmitate tracer 
infusate for entry into the bloodstream.  The tracer is then infused at a constant rate before 
exercise (until equilibration is reached) and during exercise.  Frequent samples are taken to 
ensure proper measurement.  Plasma Ra and Rd are calculated during exercise using non-steady 
state equations (Wolfe 1992) for stable isotopes as follows (Goodpaster 2002): 
 
 
Ra= {F-Vd[(C2+C1)/2][(E2-E1)/(t2-t1)] 
                             [(E2+E1)/2] 
  
 Rd=Ra × Vd ×[(C2-C1)/(t2-t1)] 
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  F = infusion rate Vd = palmitate volume of distribution 
 C2;C1 = substrate concentrations at times t2;t1, respectively. 
 
When measuring the Ra of FFA in plasma with stable isotopes, it is assumed that all the 
FFA released from triglyceride is oxidized.  However, it is possible that FFAs are re-esterified, 
causing an underestimation of oxidation.  Because glycerol cannot be turned back into 
triglyceride, measurement of glycerol turnover can provide evidence about lipolysis (Wolfe 
1992).   
When FFA and glycerol tracers are used in conjunction with indirect calorimetry, 
quantification of substrate oxidation can be established.  Labeled CO2 is used in conjunction with 
labeled substrate to determine the enrichment of CO2 in expired air.  Due to the lengthy period of 
time it would take for labeled breath to equilibrate, a primer bolus of bicarbonate is infused into 
the subject at the same time as the primed bolus of the tracers. The equation used to calculate the 
oxidation of plasma FFA is: 
V13CO2(mmol/kg/min) = [ECO2- Ebkg) × VCO2
ECO2 = mean breath 13C/12C ratio  
Ebkg = breath 13C/12C ratio at rest before tracer infusion   
Moles of gas obtained from IC can be converted to liters of O2 consumed and CO2 
produced per mmol/min, as 1 mole of gas = 22.4 liters.  Therefore, direct comparisons of IC and 
tracer results can be made.   
Since it is possible to have tracer loss in the TCA cycle from labeled expired air, it has 
been suggested that the acetate recovery factor (Sidossis 1995; Schrauwen 1998; Schrauwen 
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2000) be determined for each subject to correct for this loss (Schrauwen 2000; Borghouts 2001).  
This requires a separate exercise trial to establish the acetate correction factor if only stable 
isotopes are utilized. 
Although direct measures of nonplasma fatty acid oxidation and glycogen oxidation 
cannot be made with tracers and IC, calculations for these substrate pools can be indirectly 
ascertained.  Nonplasma fatty acid oxidation (presumably IMTG) can be calculated as the 
difference between the total fatty acid oxidation derived from IC and total plasma FFA oxidation 
derived from the [1-13C] palmitate tracer.  Stable isotope enrichments are measured by gas 
chromatography/mass spectrometry (GS/MS).   
3.1.7    DATA ANALYSIS: 
 Independent t-tests were used to test for significant differences between IMTG of elderly 
versus younger individuals. Subjects were matched for gender and percent body fat.  Muscle 
biopsy samples from the younger control population were obtained from a database of previously 
studied individuals, with the younger subjects having the same exclusionary criteria and 
sampling protocol for the biopsy as the elderly.  
Repeated measures ANOVA was used to test for differences between plasma metabolites 
and hormonal values at baseline and during exercise.  Spearman’s Rho correlation coefficients 
were used to determine the relation between substrate content and rates of substrate utilization 
during exercise averaged over the 60- minute bout of exercise.  Spearman’s Rho correlation 
coefficients were also used to examine the relationship between oxidative capacity of muscle and 
rates of NPFA utilization during exercise averaged over the 60-minute bout of exercise.  A 
significance level of p<.05 was considered significant.  Due to technical difficulties, the glycerol 
samples were not available at the present time, and were not included. 
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4. Chapter 4 
4.1   Results 
4.1.1 IMTG Comparison 
A primary objective of this study was to determine differences in IMTG content between 
old and young individuals.  There was no difference in IMTG content (p= 0.791) between 
thirteen healthy elderly subjects aged 67 + 2 and younger individuals aged 39 + 6 years (Table 
4). The older subjects were those who were recruited to participate specifically in these studies of 
substrate metabolism, while the younger subjects were accessed by database of participants of 
previous studies in the laboratories of Drs. Kelley and Goodpaster.  Older subjects were matched 
with younger subjects according to gender and % body fat.  Subject descriptive characteristics 
are shown in Table 1.  Independent t-tests showed no significant differences between the elderly 
and younger group for % body fat, FFM, FM, BMI, weight, or height.   
Table 4:  Subject Descriptive Characteristics for IMTG Comparison 
 
     Elderly Group   Younger Group 
N (8 women, 5 men)   
IMTG (AU) 22.90 + 7.07 23.11 + 13.38 
Weight (kg) 77.0 + 9.45 81.2 + 14.48 
Height (m) 1.66 + 0.09 1.69 + 0.10 
Body fat (%) 31.8 + 7.37 31.6 + 8.04 
BMI (kg/m2) 28.0 + 3.72 27.7 + 4.32 
FM (kg) 24.6 + 6.94 24.7 + 7.10 
FFM (kg) 52.4 + 8.17 54.6 + 13.22 
Values are means + SD; N=13 in each group; BMI, body mass index; FM, total body fat; FFM, fat free mass; 
IMTG, intramuscular triglyceride; AU units, arbitrary units of density of Oil Red O staining.   
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4.1.2 Baseline Parameters 
Fasting blood measures for the elderly subjects at screening, prior to the sub-maximal 
exercise bout, are reported in Table 5.  These subjects were sedentary by self-reported structured 
physical activity of less than two days per week at screening.  Physical fitness determined by 
rates of peak oxygen consumption during a graded cycle ergometer exercise test was 1.59 + 0.11 
L/min and subjects reported expending roughly 278 kcals/week in lifestyle physical activity 
(Table 6).   
 
Table 5:  Subject Fasting Blood Measures at Screening 
 
Plasma glucose (mg/dl) 91 + 3 
Insulin (uU/ml ) 11.1 + 1.6 
FFA (umol/l ) 602 + 55 
Total Cholesterol (mg/dl) 204 + 6 
Triglycerides (mg/dl) 143 + 84 
HDL (mg/dl) 59 + 4 
LDL (mg/dl) 123 + 8 
Values are means + SE; N=16; FFA, free fatty acids; HDL, high density lipoprotein; LDL, low density lipoprotein.  
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Table 6:  Physical Fitness, Self-reported Physical Activity and Sub-maximal Exercise Responses of Subjects 
VO2peak (L/min) 1.59 + 0.11 
MAQ (kcal/wk) 278 + 84 
Fat Oxidation 
(µmol/kgFFM/min) 
18.39+ 1.35 
Fat Oxidation  
(proportion of energy, %) 
53.95 + 4.57 
Relative Exercise Intensity 
(%VO2max) 
57.6 + 0.02 
RER 0.84 + 0.01 
Values are means + SE; N=16; MAQ, Modifiable Activity Questionnaire; Fat oxidation reported as mean rates of fat 
oxidation during 30-60 min of sub-maximal exercise; RER, respiratory exchange ratio. 
 
4.1.3 Plasma Metabolite Responses to Exercise 
Free fatty acids remained relatively constant throughout the 60-minute exercise bout 
(Figure 1).  Blood glucose ranged from 5.1 + 0.09 mmol/l at rest to 4.9 + 0.10 mol/l at 60 
minutes of exercise, as depicted in Figure 2.  Blood lactate levels increased from baseline to 60 
minutes of exercise (1.0 + 0.09 to 2.2 + 0.30 mmol/l), but remained relatively constant 
throughout the exercise session (Figure 3).  No significant differences were found for values of 
FFA or glucose, but there was a significant time effect for lactate (p= 0.002) by repeated 
measures ANOVA. 
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Figure 1:  Free Fatty Acids (FFA) (mean + SE) at rest, 15, 30, 45, and 60 minutes of exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Blood glucose (mean + SE) at rest, 15, 30, 45, and 60 minutes of exercise 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Plasma Lactate concentrations (mean + SE) at rest, 15, 30, 45, and 60 minutes of exercise. 
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4.1.4    Hormonal Response to Exercise 
 Insulin levels decreased slightly from baseline (11.1 + 1.6 µU/mL) to 60 minutes of 
exercise (9.3 + 1.3 µU/mL) (Figure 4), but they were not statistically significant.  
Norepinephrine levels rose from a baseline value of 361 + 67 pg/mL to 582 + 66 pg/mL at 60 
minutes of exercise (Figure 5).  Repeated measures ANOVA revealed a main effect of time for 
norepinephrine levels (p=.0195). 
 
 
 
 
 
 
 
Figure 4: Plasma Insulin concentrations (mean + SE) at rest, 30, and 60 minutes of exercise. 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure 5: Plasma norepinephrine (NE) concentrations (mean + SE) at rest, 30, and 60 minutes of exercise. 
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4.1.5    Substrate Oxidation 
RER obtained by indirect calorimetry was 0.77 at rest and averaged 0.84 throughout the 
duration of the 60-minute exercise bout (Figure 6).  Fat oxidation during the sub-maximal 
exercise bout was 18.39 µmol·kgFFM·min, providing fifty-four percent of the energy utilized for 
the 60-minute exercise bout (Figure 7).  Exercise was performed at 58% of VO2peak.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: RER concentrations (mean + SE) at rest, 15, 30, 45, and 60 minutes of exercise. 
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Figure 7: Total energy expenditure during 60 minutes of sub-maximal exercise. 
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4.1.6    Fatty Acid Metabolism Determined by Stable Isotope Turnover 
hout the sub-
maxima
respectively.  Palmitate Ra (Figure 11) and FFA Ra (Figure 12) showed similar patterns 
 
Isotopic enrichment of palmitate remained relatively constant throug
l exercise bout (Figure 8).  Substrate kinetics were calculated from the last 3 time points; 
30, 45 and 60 minutes of exercise.  Plasma fatty acid oxidation derived from the recovery of 
labeled C13 in breath is depicted in Figure 9.  Values increased from baseline to exercise at 15 
minutes, but remained relatively constant through 30, 45, and 60 minutes of exercise, 
throughout the 60-minute exercise bout.   
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Figure 8: Isotopic enrichment of palmitate in plasma (mean + SE) at rest, 15, 30, 45, and 60 minutes of 
 
exercise. 
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Figure 9: 13C/12C palmitate in breath ratio (mean + SE) at rest, 15, 30, 45, and 60 minutes of ex ise. 
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Figure 10: Isotopic enrichment of glucose in plasma (mean + SE) at rest (-60, -45, -30,
30, 45, and 60 minutes of exercise. 
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igure 11: Fatty acid of appearance (Ra) (mean +
 
 
 
 
 
 
 
 
 
 
 
 
 
F  SE) in µmol/kgFFM/min at 15-30, 30-45, and 45-60 minutes 
f exercise. 
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F : Free fatty acid (FFA) rate of appearance (Ra) (mean + SE) in µmol/kgFFM/min at 15-30, 30-45, 
nd 45-60 minutes of exercise.  a
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Figure 13: Glucose rate of appearance (Ra) (mean + SE) in µmol/kgFFM/min at -45,-30, -15, 0, 15, 30, 45, and 
60 minutes of exercise. 
 
Glucose enrichment increased from baseline (measured at 15 minute increments 60 
minutes prior to the exercise bout) to exercise, but also remained relatively stable during the 60-
minute exercise bout (Figure 10).  Glucose Ra remained constant throughout the baseline 
measurements and exercise measurements.  However, there was an increase in glucose Ra from 
baseline to exercise (Figure 13).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Rates of plasma, non-plasma, and total fatty acid oxidation (mean + SE) during exercise. 
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The older subjects oxidized a significantly higher amount of non-plasma fatty acids 
(11.12 + µmol/kgFFM/min) than plasma fatty acids (6.21 + 1.15 µmol/kgFFM/min) during the 
exercise bout (Figure 14).  Similarly, glycogen oxidation was higher than plasma glucose 
oxidation during exercise, as shown in Figure 15. 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Rates of plasma glucose, estimated glycogen, and total glucose oxidation (mean + SE) during 
exercise. 
 
Percent contribution of the various substrates is depicted in Table 16.  NPFA accounted 
for roughly 33% of total energy expenditure during exercise, whereas plasma fatty acids 
accounted for about 19%.  Plasma glucose and muscle glycogen accounted for about 22% and 
26% of total energy expenditure during exercise, respectively.    
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
Elderly
G
lu
co
se
 O
xi
da
tio
n 
(u
m
ol
/k
gF
FM
/m
in
)
Plasma
Non-plasma
Total
 52
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Relative contribution of the various substrates to total energy expenditure in the elderly (mean + 
SE) during exercise. 
 
4.1.7    Correlations between substrate content, oxidative capacity, and fat oxidation 
 There was a significant negative association between IMTG content by Oil Red O 
staining and fat oxidation (rho= -0.5989; p=0.03) induced by sub-maximal exercise in the older 
subjects.  A negative association also existed between IMTG content and oxidative capacity of 
muscle (SDH staining) (rho= -0.6485; p=0.04).  No significant association between oxidative 
capacity and rates of NPFA oxidation in the elderly during exercise existed, however, there was 
a trend toward significance between oxidative capacity and plasma fat oxidation (rho= 0.5245; 
p=0.08).   
 VO2peak was marginally correlated with fasting insulin levels (rho=-0.4857; p=0.056) 
and HOMA IR (rho=-0.4441; p=0.0848).  However, no significant differences were found for 
IMTG content and fasting insulin or HOMA IR or fat oxidation and fasting insulin or HOMA IR. 
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5.  Chapter Five
5.1   Discussion 
5.1.1   IMTG and Aging 
A primary objective of this study was to determine whether older individuals have greater 
IMTG compared to younger subjects. Contrary to our hypothesis, IMTG stores were not 
significantly different between older and younger subjects who were matched for generalized 
body composition, including body fat and lean mass. This was an important finding given the 
recent evidence suggesting that higher IMTG is linked to age-associated insulin resistance 
(Petersen 2003).  
Although it has been suggested that increased IMTG stores occur with aging in both 
humans (Cree 2004) and rodents (Tucker 2003), the available evidence that higher IMTG is 
directly related to aging is not clear. In aging rats, fatty acid uptake under insulin-stimulated 
conditions was significantly increased and correlated with rates of triglyceride synthesis (Tucker 
2003).  The authors speculated that the increase in fatty acid uptake could be the preliminary 
factor in the accumulation of triglyceride within skeletal muscle.  Other factors associated with 
increased IMTG levels in humans include obesity (Goodpaster 2000) and paradoxically, chronic 
exercise training (Martin, Dalsky et al. 1993). We matched our older and younger subjects in this 
comparison for level of obesity, and both groups were sedentary by self-reported lack of 
participation in regular exercise. However, we were not able to match these subjects according to 
levels of physical fitness, which may have confounded any age-related differences. This is in 
contrast to Petersen and colleagues who found higher IMTG levels in older subjects, although 
they did not obtain objective measures of physical activity or physical fitness (Petersen 2003).  
This contrast could be related to several methodological differences between the two studies.  In 
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the current study, IMTG content was assessed by microscopy, with Oil Red O staining of a 
muscle biopsy sample, whereas Petersen et al. (Petersen 2003)used NMR 1H spectroscopy to 
obtain intramyocellular lipid content (IMCL).     
It is possible that the NMR 1H spectroscopy methods can be confounded by the technical 
challenges of quantifying IMTG defined as IMCL in older subjects who typically have a 
considerable amount of extracellular lipid in muscle. The necessity to use relatively large voxel 
sizes for these spectroscopic measurements makes the IMCL quantification difficult.  It is also 
possible that biochemical determinations of IMTG may also be confounded by small amounts of 
extracellular lipid in the muscle specimen (Guo 1999), which again, could be more problematic 
in older subjects. Thus, the direct quantification approach of lipid staining of IMTG in the 
current study is perhaps the first direct comparison of IMTG levels in older versus younger 
humans suggesting that higher IMTG is not a function of age per se, at least in these relatively 
healthy older men and women.  
In addition, caution must be used when comparisons are made between muscle samples 
from different locations in the body, as skeletal muscle fiber types and ratios vary, depending on 
the specific muscle studied (J. Keul 1972; Squire 1986).  In the current study, IMTG content of 
the vastus lateralis muscle was measured, whereas IMCL content of the soleus muscle was 
measured in the study by Petersen et al.(Petersen 2003)  Therefore, specific muscles with 
specific fiber type ratios may be more susceptible to the accumulation of IMTG. 
5.1.2   IMTG Content and Insulin Resistance 
 High levels of IMTG have been associated with insulin resistance and Type 2 Diabetes 
in younger, sedentary populations (Goodpaster, Thaete et al. 1997; Pan, Lillioja et al. 1997; 
Ebeling, Essen-Gustavsson et al. 1998; Goodpaster, Kelley et al. 1999; Krssak, Falk Petersen et 
al. 1999; Manco, Mingrone et al. 2000; Kelley 2001; Perseghin 2003).  It has also been 
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suggested that higher IMTG in the elderly characterizes age-related insulin resistance (Petersen 
2003). Therefore, high IMTG levels in the elderly could predispose this population to these 
metabolic derangements. In a study by Cree et al., increases in IMTG seen in the elderly were 
significantly correlated with insulin sensitivity (Cree 2004), even after controlling for body fat. 
Although insulin sensitivity was not measured in the current study, higher fasting insulin levels 
and HOMA IR were not significantly associated with IMTG content.  
5.1.3   IMTG Content and Fat Oxidation 
Another primary objective of this study was to examine whether fat oxidation during sub-
maximal exercise was associated with substrate, i.e. IMTG availability. Increased levels of 
IMTG by ORO staining were associated with lower fat oxidation during exercise in the present 
study.  This is in accord with other studies suggesting that IMTG may link impaired fatty acid 
metabolism and insulin sensitivity (Phillips, Green et al. 1996; Goodpaster, Thaete et al. 1997; 
Pan, Lillioja et al. 1997; Kelley 2001). Thus, these data would indicate that a reduced capacity 
for fat oxidation may contribute to lipid accumulation within the muscle in sedentary older 
adults.  It is possible that an increased ability to oxidize fat would protect older subjects against 
insulin resistance and age-associated metabolic diseases such as type 2 diabetes. In support of 
this concept, Petersen et al. (Petersen 2003) demonstrated that older subjects who were insulin 
resistant and had higher IMTG levels also had a lower capacity for oxidative metabolism 
compared to younger subjects. These data alone would suggest that a low capacity for fat 
oxidation leads to IMTG accumulation. 
However, in a recent review, Kelley and Goodpaster (Kelley 2001) suggested that IMTG 
may not result in adverse metabolic conditions in the presence of efficient fat oxidation by 
muscle.  This is evidenced in highly trained endurance athletes, who possess greater muscle fat 
stores, but are highly insulin sensitive (Goodpaster, He et al. 2001). Further, a sub-group of 
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subjects in the current study who went on to participate in a 12-week aerobic exercise program 
had a significant increase in IMTG (Pruchnic et al), providing additional evidence that exercise 
training may increase IMTG, even in older subjects. This is consistent with the notion that 
triglycerides themselves do not confer insulin resistance (Yu 2002), but rather diacylglycerol and 
ceramides may have direct effects on insulin signaling (Schmitz-Peiffer 2000).  This is also 
consistent with studies showing that IMTG is a readily available energy source during physical 
exercise (Hurley, Nemeth et al. 1986; Romijn 1993).  Therefore, increased IMTG stores in the 
presence of enhanced muscle oxidative capacity may represent an increased ability of the muscle 
to oxidize fat.   
5.1.4 Aging and Fat Oxidation 
Fat oxidation rates induced by sub-maximal exercise in the present study are consistent 
with those reported by Sial et al. In that study, elderly men and women had lower fat oxidation 
during 60 minutes of moderate intensity (55.7 + 3.1% VO2peak ) cycle ergometry exercise (Sial, 
Coggan et al. 1996) when compared to a younger, control group matched for gender and FFM. It 
has been suggested that aging is associated with a reduced ability to utilize fatty acids (Coggan, 
Spina et al. 1992; Calles-Escandon 1995; Proctor, Sinning et al. 1995; Sial, Coggan et al. 1996; 
Petersen 2003).  Perhaps the reduction in muscle size and metabolic function seen in the elderly 
are associated with this decrease in oxidative metabolism.  Calles-Escandon et al. (Calles-
Escandon 1995) found a reduction in basal fat oxidation with increasing age in a group of 
women.  The single best predictor of the decline in basal fat oxidation in their study (Calles-
Escandon 1995) was a reduction in FFM.  Preservation of FFM with exercise training may 
reduce the decrease in fat oxidation seen in the elderly.   
It has been suggested by Coggan et al. (Coggan 1993) that the lower capacity for fat 
oxidation in older adults can partly be explained by the physical inactivity that accompanies 
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aging. In support of this, this same group has also demonstrated increases in exercise-induced fat 
oxidation with exercise training. This is also consistent with a recent study from our group 
showing that older subjects have a significantly greater reliance on fat as an energy source during 
exercise following 12 weeks of exercise training (Pruchnic 2004). Therefore, it may not be the 
aging process itself, but a sedentary lifestyle that contributes to these metabolic insufficiencies 
associated with the elderly.  To further support this idea, Rimbert et al. found that impairment of 
muscle fat oxidative capacity was not correlated with age, but with physical inactivity and 
insulin sensitivity in a group of elderly (64 + 3 yrs) sedentary subjects (Rimbert 2004).  In the 
current study, higher fasting insulin levels and HOMA IR were marginally associated with lower 
fitness levels.  This association may have been greater with a greater sample size.      
5.1.5 Obesity and Fat Metabolism     
Substrate availability and capacity for oxidative metabolism are two primary factors that 
could influence fat oxidation during exercise. Our finding that lower fat oxidation during 
exercise was associated with higher IMTG content is in apparent contrast to other investigations 
demonstrating that obese individuals, who usually exhibit higher IMTG content, oxidize more fat 
during exercise than lean controls (Horowitz 2000; Goodpaster 2002). One could surmise from 
these studies that during exercise increased IMTG oxidation is associated with higher IMTG 
availability. This phenomenon may represent an adaptation to avoid insulin resistance by 
utilizing available IMTG’s during exercise.  This, however, does not appear to be the case for the 
older subjects in this study.  In the present study, oxidative capacity of muscle was not related to 
fat oxidation during sub-maximal exercise in the elderly, however, lower oxidative capacity of 
muscle was associated with higher IMTG stores.   
The increase in fat oxidation seen in obese individuals during exercise is in contrast to 
reports of lower fasting rates of fat oxidation in the presence of high IMTG content with obesity 
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(Kelley, Goodpaster et al. 1999). This is also consistent with lower oxidative enzyme capacity in 
obesity (Kelley 2001) and obesity-associated insulin resistance (Kelley 2001). In another study 
of overweight women, normal insulin sensitivity and lower IMTG content was associated with 
higher fasting lipid oxidation (Perseghin 2002). Taken together, these data suggest a complex 
association between substrate availability and capacity for oxidative metabolism in obesity as 
well as in older adults. Future studies are needed to explore this further. 
5.1.6 Aging and Carbohydrate Oxidation  
Increased skeletal muscle glycogen utilization during exercise in the aging has been 
demonstrated in both human (Sial, Coggan et al. 1996) and rat studies (Cartee 1994). This is 
consistent with the present study, in which carbohydrates accounted for about half of the total 
substrate utilized during the 60-minute sub-maximal exercise bout, with muscle glycogen 
accounting for roughly 22% of this oxidation.  The increased oxidation of carbohydrate in the 
elderly may reflect the decline in skeletal muscle respiratory capacity, and subsequent decrease 
in fat oxidation seen in this group (Meredith, Frontera et al. 1989; Coggan, Spina et al. 1992; 
Sial, Coggan et al. 1996). Lower muscle glycogen levels have also been found in the elderly, and 
may be linked with decreased insulin sensitivity (Meredith, Frontera et al. 1989).  If the elderly 
possess less muscle glycogen stores at the start of exercise, depletion could occur sooner, 
creating earlier fatigue.      
5.1.7  Conclusion 
The results of this study indicate that IMTG content is similar between older and younger 
individuals when matched for percent body fat and gender, instead of being higher in the elderly 
as originally hypothesized.  As predicted, IMTG content was not associated with higher NPFA 
oxidation, although higher IMTG was associated with lower total fat oxidation during sub-
maximal exercise.  Oxidative capacity of muscle was not associated with NPFA oxidation as 
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originally hypothesized.  Low capacity for fat oxidation was associated with higher IMTG 
content, suggesting that reduced capacity for fat oxidation in muscle leads to IMTG 
accumulation.  Caution must be taken when interpreting these results due to the small sample 
size of 16 subjects.  We saw several trends that may have reached statistical significance had our 
sample size been larger.   
Other limitations to the present study included the lack of fitness data in the younger, 
comparison group, which may have influenced IMTG content in this group, as well as the lack of 
a control group for the sub-maximal exercise bout.  Finally, the current investigation was a 
preliminary, cross-sectional study designed to determine the relative content of IMTG in elderly 
and its relation to substrate metabolism during sub-maximal exercise.  Training studies are 
needed to gain a better understanding of the relationship between IMTG content and substrate 
metabolism, where each subject can act as their own control.       
5.1.8 Future Research Recommendations 
Based upon the literature, a relationship exists between IMTG, insulin resistance and 
decreased fat oxidation.  However, it is unclear what role IMTG content plays in this metabolic 
dysregulation.  Specifically, does IMTG content precipitate or result in the decrements in fat 
oxidation and is this phenomenon consistent in different populations (ie. elderly/obese/diabetic)?    
Exercise training studies have shown improvement in muscle fat oxidative capacity in the 
elderly, but the relationship to IMTG content and NPFA utilization deserve further examination.  
Finally, due to the small sample size in the present investigation, gender comparisons of IMTG 
content and substrate utilization in the elderly were not possible, and should be accounted for in 
future studies.  
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DESCRIPTION:   
Why is this research being done?  
 I understand that I have been asked to participate in a research study that will assess how my 
body burns fat during exercise, which may be important in determining the relationship of aging 
and physical fitness, and may provide important information about how to design  
effective programs to help prevent the effects of aging on the loss of muscle function.  
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Who is being asked to take part in this research study?   
I am being asked to participate in this study because I am a normal, healthy volunteer between 
the ages of 65-75.  I will have an examination to determine if I am in good general  
health for participating in this study, and these results will be given to me for my records.  If I 
qualify I will be one of 20 subjects in this study. 
 
What procedures will be performed for research purposes?   
If I participate in the study, I will be asked to participate in the following procedures:  (1) A scan 
(called a DEXA scan which is similar to an x-ray) to measure total fat content of my body; (2) an 
exercise test to determine my level of fitness; (3) and two exercise tests lasting one hour which 
will determine how my body burns fat; (4) a needle biopsy to obtain a small piece of muscle 
tissue from my thigh to evaluate the amount of fat contained in my muscle; and (5) a Magnetic 
Resonance Imaging (MRI) scan (like an x-ray but with no radiation) to measure the amount of 
fat and muscle in the leg. The purpose of these tests is to determine how aging and the amount of 
fat and muscle in the leg affect the body’s ability to burn fat during exercise. Following these 
tests, I will participate in a 12-week exercise program to determine how exercise may help 
prevent some of the negative effects of aging on the body's metabolism. 
On one morning I will be scheduled for a screening at the General Clinical Research Center 
(GCRC) to see if I qualify for this study.  This will include a physical exam, blood draw and a 
graded exercise test (stress test) to assess physical fitness. This test will take approximately one 
hour.  On a separate day I will be scheduled for an outpatient visit to the GCRC at the University 
Hospital for an MRI scan of the mid thigh, a DEXA scan to measure body fat and the muscle 
biopsy. The MRI, DEXA and muscle biopsy will each take about one hour (three hours total for 
that day). Approximately one week following the outpatient visit, I will be admitted for an 
overnight visit to the GCRC and the following morning asked to perform a one hour, relatively 
easy exercise bout to assess fat metabolism during exercise. Approximately one week following 
this, I will come back to the GCRC for another overnight visit and relatively easy exercise bout 
to assess fat metabolism during exercise.  This week I will also begin participation in a 12-week 
exercise training program. Following the training program, I will be asked to undergo the 
exercise tests, DEXA, MRI and muscle biopsy in the same sequence and in the same manner as 
prior to exercise training. 
 The MRI scan involves lying on a table for about 45 minutes so that the fat in my thigh 
muscle can be measured. 
 The DEXA scan is performed similar to an x-ray study and I will lie on an examination 
table in a room with the DEXA scanner for approximately 30 minutes. The test is painless except 
for any discomfort I may experience because of lying on my back on the firm examination table.  
 
Subject’s initials______________ 
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On the same morning as the DEXA and MRI scans, a small sample of muscle tissue (the 
size of pencil tip) from the thigh will be obtained and evaluated. On the outer surface on one 
thigh an area the size of a quarter will be numbed by an injected anesthetic and a biopsy 
needle will be passed into the muscle in order to obtain a small piece of muscle. 
 At the screening examination to measure my fitness level, I will undergo an exercise test 
on a stationary bicycle. My heart rate will be monitored by adhesive pads attached to my chest 
that are connected to a heart monitor.  I will be asked to breathe through a mouthpiece in order to 
measure how much oxygen my body is using as I pedal the bike. Every two minutes the bike will 
be adjusted to make pedaling more difficult, and I will be asked to keep  
working until I am too tired to continue. If I develop a pain in my chest or have particular 
patterns on the heart monitor, I will be asked to stop pedaling. This test will take approximately 
one hour. 
 Participation will also involve four overnight admissions to the University of Pittsburgh 
General Clinical Research Center (GCRC).  Prior to each overnight admission, I will be 
instructed to avoid strenuous physical activity for two days prior to this study and to eat at least 
200 g of carbohydrate per day for the three days preceding the study to make sure that my energy 
levels are high for the exercise bout. I will be admitted in the evening and receive a normal 
dinner that evening and then not eat until after the exercise study is completed the following day, 
although I can have water. On that evening in the GCRC I will not perform any type of rigorous 
physical activity. The next morning I will perform the exercise test. At about 6:30 A.M., I will be 
transported to the Obesity Nutrition Research Center Laboratory on the 8th floor Montefoire 
University Hospital where an intravenous catheter (plastic needle in my vein) will be placed in 
my arm to introduce glucose and fatty acid metabolic tracers into my blood. These tracers, 
containing absolutely no radioactivity, are used to measure my body’s use of glucose and fat. 
Another catheter will be placed in the vein of my hand to periodically sample blood. For the 
entire study including rest and exercise, I will have 8 blood samples taken, each being about 5 ml 
or about 3 tablespoons total. 
 After starting the tracers at about 7:30 A.M., I will rest in a chair for approximately two 
hours before I get on a stationary bike at ~ 9:30 A.M. for exactly one hour of cycling. The 
exercise on the bike will be relatively easy in the beginning but may become more difficult as 
my muscles tire. During the exercise, I will be wearing a belt around my chest, which contains a 
transmitter to measure my heart rate. I will be asked to breathe through a mouthpiece connected 
to a breathing valve for 5 minutes at four different times during the exercise test in order to 
collect my expired air for the measurement of my exercising metabolism. During this period I 
will be breathing in normal room air. A nurse will take a 5 ml blood sample (about 1 teaspoon) 
from me every 15 minutes during exercise. I will be allowed to drink water at any time during 
exercise and cooled by a fan if I request.  
 
Subject’s initials______________ 
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RISKS AND BENEFITS:  
What are the possible risks, side effects, and discomforts of this research study?  
Participation may entail some risks. These are related to exercise, blood sampling and exposure 
to radiation from the DEXA scans: 1) The risks of inserting a catheter into a vein for blood 
sampling and the muscle biopsy procedure are bleeding, bruising and discomfort.  
In our experience using similar protocols, subjects have not experienced any adverse effects from 
these procedures other than a small amount of residual localized soreness at the blood sampling 
or biopsy sites.  2) Participation in this research study involves a minimal radiation exposure 
from the DEXA. The amount of radiation exposure that you will receive from this procedure is 
about 0.06 mRAD to your whole body. For comparison, radiation workers are permitted, by 
federal regulation, a maximum whole body radiation exposure of 5 RADS per year. There is no 
minimum amount of radiation exposure that is recognized as being totally free of the risk of 
causing genetic mutations (abnormal cells) or cancer. However, the risk associated with the 
amount of radiation exposure that I will receive from taking part in this study is felt to be low 
and comparable to everyday risks.  3) MR imaging has certain conditions that would exclude me 
from participating in this study.  These include cardiac pacer, shrapnel, or other metal devices. 
Metal objects present in the body could be moved by the large magnet involved in the MRI, and 
such movement could cause serious injury. Pregnancy and fear of closed spaces are also reasons 
to be excluded from the study.  No serious biological effects have been reported from being in a 
magnet.  If I experience a fear of the confined space while in the magnet, I can terminate the 
study. More severe reactions such as respiratory distress or severe drop in blood pressure are 
rare. Trained medical personnel are always in attendance during these studies; 4) The exercise 
test (VO2max) and 60 minute exercise bout may cause muscle soreness or fatigue, but in adults 
without a known history of heart disease, the risk of heart attack or death from these tests is 
extremely low. American College of Sports Medicine (ACSM) criteria will be used to halt 
maximal exercise testing should adverse cardiovascular responses develop. I will be encouraged 
to finish the 60 minute exercise bout, but if I fail to keep a pedaling rate of at least 60 
revolutions/minute, the test will be stopped. In the case of an adverse event during either of the 
exercise tests my primary care physician will be notified. 
 
What are possible benefits from taking part in this study? 
I will not benefit personally from participation in this study except to the extent that I may 
benefit from participation in these exercise studies because of the health benefits associated with 
regular exercise.  Information on exercise capacity, fitness and energy metabolism during 
exercise will be shared with me if I desire. This will include a copy of the maximal exercise test 
and body composition results. 
I understand that I should inform the investigators if I have participated in any other research 
study during the previous year, and I have done so. Prior participation in another research study 
does not necessarily exclude me from this study. However, this information may be  
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used to determine whether or not any prior participation in research studies may affect the  
results of this study. I understand that this study is a research study and may not be of direct 
benefit to me. If requested, a report will be generated for my medical record that will include any 
information important for my medical care.  
 
NEW INFORMATION:   
If I agree to take part in this research study, will I be told of any new risks that may be found 
during the course of the study? 
If new information, either good or bad, about this study comes to the attention of the investigator 
during the course of this study which may relate to my willingness to participate, it will be 
provided to me or my representative.  A copy of this consent form will be given to me to keep 
for careful rereading. 
 
COSTS AND PAYMENTS:  
Will I or my insurance provider be charged for the costs of any procedures performed as part 
of this research study? 
I understand that neither I, nor my insurance provider will be required to pay for any procedures 
associated with this research study.  
 
Will I be paid if I take part in this research study? 
I will receive a payment of $200 for the completion of the first series of procedures, including 
the exercise trials, muscle biopsy, DEXA, MRI and VO2max procedures. After completing the 
exercise training regime, I will be asked to repeat these procedures, and if successful, I will 
receive an additional $300. Parking costs or transports, in an amount not to exceed $10 will be 
given to volunteers. 
 
COMPENSATION FOR ILLNESS OR INJURY:  
Who will pay if I am injured as a result of taking part in this study? 
University of Pittsburgh investigators and their associates who provide services at the UPMC 
Health System (UPMC HS) recognize the importance of my voluntary participation to their 
research studies. These individuals and their staffs will make reasonable efforts to minimize, 
control, and treat any injuries that may arise as a result of this research. If I believe that I am 
injured as a result of the research procedures being performed, please contact the Principle 
Investigator listed on the cover sheet of this form or the University of Pittsburgh Institutional 
Review Board (412-578-3424). Emergency medical treatment for injuries solely and directly 
relating to my participation in this research will be provided to me by hospitals of UPMC HS. It 
is possible that the UPMC HS may bill my insurance provider for the costs of this emergency 
treatment, but none of these costs will be charged directly to me. If my research-related injury 
requires medical care beyond this emergency treatment, I will be responsible for the cost of this 
follow-up care unless otherwise specifically stated below. I will not receive monetary payment 
for, or associated with, any injury that I suffer in relation to this research. 
Subject’s initials______________ 
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CONFIDENTIALITY:   
Who will know about my participation in this research study? 
Any information about me will be handled in a confidential manner consistent with other   
medical records. Information obtained about me from this research project will be part of my  
research record.  Research records will be kept in locked files in the office of Dr. Goodpaster. All 
data obtained will be maintained by Dr. Goodpaster’s laboratory for a period of at least five 
years upon termination of this study with access restricted to authorized personnel only.  
However, in unusual circumstances, my research records may be inspected by appropriate 
government agencies, or released in response to an order from a court of competent jurisdiction. 
I will not be identified by name in any publications but consent to publication of any information 
for scientific purposes so long as my identity is not revealed.  In signing this form I consent to 
the publication of the results of the study for scientific purposes. 
 
RIGHT TO WITHDRAW:   
Is my participation in this research study voluntary? 
I understand that I do not have to take part in this research study. Should I change my mind I can 
withdraw from the study at any time. Other care and benefits will be the same whether I 
participate in this research study or not.   
 
If I agree to take part in this research study, can I be removed from the study without my 
consent?  
I should also understand that I may be withdrawn from the study by the investigators if they feel 
my health is in danger, if any untoward findings develop during the course of the study, or if I 
have failed to follow their instructions. 
 
VOLUNTARY CONSENT:  
I certify that I have read the preceding, or it has been read to me, and I understand its contents. 
Any questions I have pertaining to the research have been, and will continue to be answered by 
the investigators listed at the beginning of this consent form at the phone numbers given. Any 
questions I have concerning my rights as a research subject will be answered by the Human 
Subjects Protection Advocate of the IRB Office, University of Pittsburgh (412-578-8570). A 
copy of this consent form will be given to me. My signature below means that I have freely 
agreed to participate in this project. 
 
Subject's signature _____________________           Date and time   _____________                                       
 
    
Witness ________________________                      Date and time _____________                                         
 
****************************************************************************** 
INVESTIGATOR'S CERTIFICATION:  I declare that I have personally explained the above 
information to the patient or the patient's legal representative.  
Investigator's signature  ________________________                  Date __________
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FAME STUDY GENERAL HEALTH HISTORY 
 
Please fill out this questionnaire carefully: 
 
Name                                                                                                         Date___________                   
Last                      First               M.I. 
 
Street Address                                                                                         Home Phone (        )                  
 
City                                               State              Zip Code                  Work Phone (        )                    
 
1.  Sex       M              F            2. Age                 3. Birthdate            /          /           
                                             month   day     year 
 
4. Current Weight                  kg.               5. Height            cm 
 
6. Race      
1) Caucasian              
2) African American             
3) Hispanic              
4) Asian              
5) Other (please specify)                                 
 
7.  Name and phone number of friend or family member not living with you: 
 
Name                                                                            Phone Number (         )                                    
 
8.  Please list all medications that you are currently taking: 
 
 
 
Medication 
 
     Dose 
 
Reason for taking 
 
a. 
 
 
 
 
 
 
 
b. 
 
 
 
 
 
 
 
c. 
 
 
 
 
 
 
 
d. 
 
 
 
 
 
 
 
e. 
 
 
 
 
 
 
 
f. 
 
 
 
 
 
 
 
g. 
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General Health History 
9. Do you have or have you ever had any of the following medical conditions? 
 
 
Condition 
 
Check if yes
 
Date of Diagnosis 
(approximately) 
 
 
Describe the Problem 
 
a.  Heart attack 
 
 
 
 
 
 
 
b.  Angina (chest pain on  exertion) 
 
 
 
 
 
 
 
c.  Irregular heart rhythm 
 
 
 
 
 
 
 
d.  Heart failure 
 
 
 
 
 
 
 
e.  Fainting spells 
 
 
 
 
 
 
 
f.  Other heart problems 
 
 
 
 
 
 
 
g.  Liver disease 
 
 
 
 
 
 
 
h.  Kidney disease 
 
 
 
 
 
 
 
i.  Chronic diarrhea 
 
 
 
 
 
 
 
j.  Stroke 
 
 
 
 
 
 
 
k.  Substance abuse 
 
 
 
 
 
 
 
l.  Thyroid problems 
 
 
 
 
 
 
 
m.  Kidney stones 
 
 
 
 
 
 
 
n.  Gallstones 
 
 
 
 
 
 
 
o.  Gout 
 
 
 
 
 
 
 
p.  Emotional/psychiatric  
      problems 
 
 
 
 
 
 
 
q.  Diabetes 
 
 
 
 
 
 
 
r.  Cancer 
 
 
 
 
 
 
 
s.  High blood pressure 
 
 
 
 
 
 
 
t.  Circulation Problems  
 
 
 
 
 
 
u. Any other medical problems    
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ALCOHOL INTAKE 
 
1.  On how many weekdays (Monday through Friday) do you usually drink wine, beer, or 
liquor? 
 
Never                 (0)       Two days/week                (4) 
     Less than once/month                (1)       Three days/week                (5) 
      1-2 times/month                 (2)       Four days/week                (6) 
      One day/week                 (3)      Five days/week                (7) 
 
2.  On those weekdays you drink wine, beer, or liquor how many drinks do you have?                           
 
3.  On how many weekend days (Saturday & Sunday) do you usually drink wine, beer, or 
liquor? 
 
Never                 (0)  One weekend day/week              (3) 
      Less than once/month             (1)     Two weekend days/week             (4) 
      1-2 times/month                 (2) 
 
4.  On those weekend days you drink wine, beer, or liquor how many drinks do you have?                     
  
 
FOR WOMEN ONLY 
 
 1. Are you currently pregnant?       Yes             No            
 
 2. Do you plan to become pregnant in the next two years?   Yes             No            
 
 3. Have you gone through menopause or the change of life?  Yes             No            
 
 4. Have you had a hysterectomy? Yes             No                 Date of surgery            /          /           
                                 month  day  year 
 
 5. If yes, was the hysterectomy partial (uterus only) or complete (uterus & ovaries)?   
partial               complete              
 
 6. When was your last menstrual period?               /          /           
                                             month  day  year 
 
 7. Do you take:  Birth control pills?   Yes             No            
                  Estrogens (e.g., premarin)?        Yes             No            
                  Progesterone (e.g., provera)?      Yes             No        
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Current Physician: 
 
  Name   ______________________________________________                                                                    
 
  Address  _____________________________________________                                                                   
 
  City                                                                           State               Zip                            
 
  Phone Number  (          )______________                                 
 73 
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MODIFIABLE ACTIVITY QUESTIONNAIRE 
Name___________________      Date___________ 
ID#______________________ 
 
1. Please circle all activities listed below that you have done more than 10 times in the past year: 
Jogging (outdoor, treadmill) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 1      Football/Soccer⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 14 Stair Master ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  ⋅ ⋅ ⋅ 27 
Swimming (laps, snorkeling) ⋅ ⋅ ⋅⋅ ⋅ ⋅⋅ ⋅ 2      Racquetball/Handball/Squash⋅ ⋅15         Fencing ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  28 
Bicycling (indoor, outdoor) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  ⋅ 3     Horseback riding ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅16         Hiking ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  ⋅ ⋅ ⋅ ⋅  29 
Softball/Baseball ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 4       Hunting ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅17         Tennis ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 30 
Volleyball ⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅ 5       Fishing ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 18 Golf (cart) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  31 
Bowling ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 6       Aerobic Dance ⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅19 Canoeing/Rowing/Kayaking ⋅ ⋅ 32 
Basketball ⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅7        Water Aerobics ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 20 Water Skiing ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅33 
Skating (roller, ice, blading ⋅ ⋅ ⋅ ⋅⋅ ⋅ ⋅ ⋅ 8         Dancing (Square,line,,ballrm) ⋅21 Jumping rope ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅34 
Martial Arts (karate, judo) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  9        Gardening or Yardwork ⋅ ⋅ ⋅ ⋅⋅ ⋅ 22 Snow Skiing (X-C/Nordic trk) ⋅ 35 
Tai Chi ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 10         Badminton ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 23 (downhill) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 36 
Calisthenics/ Toning exercises ⋅ ⋅ ⋅ ⋅  11        Strength/weight training ⋅ ⋅ ⋅ ⋅ ⋅ 24 Snow shoeing ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 37 
Wood Chopping ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅12         Rock climbing ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 25 Yoga ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 38 
Water/coal hauling ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 13        Scuba diving ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ 26 Other ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅  39 
Walking for exercise (outdoor, indoor at the mall or fitness center, treadmill) ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅40 
 
List each activity that you circled in the “Activity” box below.  Check the months you did each activity over the past year (12 montsh) and 
then estimate the average amount of time spent in that activity. 
 
Activity     Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Average # of 
Times per 
month 
Average # of 
Minutes each 
time 
               
               
               
               
               
               
               
               
               
               
               
               
 
 
2.  In general, how many HOURS per DAY do you usually spend watching television?     ____hrs 
3.  Over this past year, have you spent more than one week confined to      Yes_______ No________  
     a bed or chair as a result of an injury, illness, or surgery?  
 
4.  Do you have difficulty doing any of the following activities? 
 a.  getting in or out of a bed or chair?    Yes_______ No________ 
 b.  walking across a small room without resting?   Yes_______ No________ 
 c.  walking for 10 minutes without resting?    Yes_______ No________ 
 
5.  Did you ever compete in an individual or team sport (not including any time spent in sports performed during 
school physical education classes)? 
 If yes, how many total years did you participate in competitive sports? _______ 
 
6.  Have you had a job for more than one month over this past year, from last _______ to this _______? 
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List all JOBS that the individual held over the past year for more than one month.  Account for all 12 months of the 
past year.  If unemployed/disabled/retired/homemaker/student during all or part of the past year, list as such and 
probe for job activities of a normal 8 hour day, 5 day week. 
 
Job 
Name 
Job 
Code 
Walk or 
bicycle 
to/from 
work 
Min/Day 
 
 
 
 
Mos/Yr 
 
Ave Job 
Schedule 
 
Day/Wk 
 
 
 
 
Hrs/Day 
Hrs. spent 
sitting at 
work 
 
 Hrs Sitting 
 
 
 
 
A 
 
 
 
 
B 
 
 
 
 
C 
          
          
          
          
 
    
Category A    Category B    Category C 
(includes all sitting activities) (includes most indoor activities)  (heavy industrial work, outdoor    
                                                                                                                                    construction, farming) 
 
Sitting    Carrying light loads   Carrying moderate to heavy loads 
Standing still w/o heavy lifting Continuous walking   Heavy construction 
Light cleaning-ironing,  Heavy cleaning-mopping, sweeping Farming-hoeing, digging 
 Cooking, washing, dusting   scrubbing, vacuuming      mowing, raking 
Driving a bus, taxi, tractor  Gardening- planting, weeding  Digging ditches, shoveling 
Jewelry making/ weaving  Painting/ Plastering   Chopping (ax), sawing wood 
General office work  Plumbing/ Welding   Tree/ pole climbing 
Occasional/short distance walking Electrical work    Water/coal/wood hauling 
    Sheep herding 
 
JOB CODES 
 
 Not employed outside of the home:   Employed (or volunteer): 
  1.  Student     6.  Armed Services 
  2.  Home Maker     7.  Office worker 
  3.  Retired     8.  Non-office worker 
4. Disabled 
5. Unemployed 
 
 
Reprinted in modified form with permission of the publisher from KRISKA, A.M., W.C. Knowler, R.E. LaPorte, et 
al.  Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians.  
Diabetes Care 13:401-411, 1990.  Copyright Diabetes Care.  
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EXERCISE TEST 
 
______________Study 
Name____________________  ID#__________    Age________ 
Wt.___________  Ht._________  APM__________ 
Resting HR_________  Resting BP_______________ 
 
Time  Women HR  BP  RPE  Men 
0-2  50 W        100 W 
2-4  75 W        125 W 
4-6  100 W        150 W 
6-8  125 W        175 W 
8-10  150 W        200 W 
10-12  175 W        225 W 
12-14  200 W        250 W 
14-16  225 W        275 W 
Termination Time______________ 
Reason for Termination______________________________ 
Peak:  HR______ BP_______________ 
Recovery: 
_____min  HR_____ BP_______________ 
_____min  HR_____ BP_______________ 
_____min  HR_____ BP_______________ 
NOTES: 
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FAME STUDY BLOOD COLLECTION SHEET:  PALMITATE 
IRB# 980276  The Effects of Exercise Training on Skeletal Muscle FFA Utilization During 
Exercise in the Elderly 
Investigators:  Bret Goodpaster, PhD (PI)  ph: 692-2437  pg: 958-6186 
  David E. Kelley, MD   ph: 692-2158  pg: 958-5200 
  Silva Arslanian, MD   ph: 692-5174 
  Fernando Boada, PhD   ph: 647-9712 
  Carena Winters-Hart, MS  ph: 692-2158  pg: 958-7925 
                         (coordinator) 
Subject Name_______________________  Date_______ 
Subject ID_______________ Visit #_____ 
Height____________cm Weight____________kg BSA____________m2
Heart Rate (rest)____________ Blood Pressure (rest)  ________________ 
 
*6,6 d2 Glucose infusate 1 ml ALIQUOT saved?_____ 
6,6 d2 Glucose prime dose of ______________ given @ __________ 
6,6 d2 Glucose infusion started @ ______ stopped @ ______ total vol infused_______ml 
*[d-5] Glycerol infusate 1 ml ALIQUOT saved?______ 
 [d-5] Glycerol prime dose of ______________ given @ __________ 
[d-5] Glycerol infusion started @ ______ stopped @ ______ total vol infused_______ml 
H2CO3 prime dose of _______________ given @ _________ 
*Palmitate infusate 1 ml ALIQUOT saved?__________ 
Palmitate infusion of ____________________________ 
  started @   ___________stopped @ ___________total vol infused__________ml 
 
*Make Draw-off Tubes for 13C Palmitate, 2H glucose, and 2H glycerol. 
*Double glucose and glycerol at the start of palmitate infusion* 
 
EXERCISE 
         Watts 
H2CO2 Bolus _______     15 min 
        30 min 
        45 min 
        60 min 
 
Acetate Start:  ____________ 
Bike Start:       ____________    VO2max=_________l/min 
              50%=__________l/min 
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BLOOD COLLECTION SHEET   ID#_____________      Visit #____ 
 
Sample Time Due 
/Drawn 
Catechol 
amines 
d2
Glucose 
FFA/ 
Palmitate 
Insulin BreathX2 Glycerol 
d-5 Glycer 
Enrichmt 
Plasma 
Glucose/ 
Lactate 
Volume/
Tube 
 5 ml 
green top 
2.5ml 
grey top 
(1) 5 ml 
purple 
3 ml 
purple 
(2) 10ml 
red 
(1) 5 ml 
purple 
0.3 micro-
tube 
Background               ***See below for background blood draw instructions*** 
Bkg         
0 min Investigators to start 6,6 d2 glucose infusion after verifying that all baseline/background was drawn 
0 min Investigators to start [d-5] glycerol infusion 
+105 min         
+110 min         
+115 min         
+120 min         
Time reset to “0”.  Exercise Test begins.  PI to start palmitate infusion/administer H2CO3 bolus/double glucose/glycerol 
15EX         
30EX         
45EX         
60EX         
 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
 
 
Background Blood Draw Instructions 
At time of antecubital line placement (and BEFORE investigators start the 6,6 d2 glucose) all of the following 
blood samples must be drawn after the Abg has been ok’d by the P.I. 
 
Two 2.5 ml grey tops (as baseline for deuterated glucose)  Keep on ice  Put small amount in microtube for plasma 
glucose/lactate analysis 
 
Three 5 ml purple tops (as baseline for FFA/glycerol enrichment, insulin and glycerol)  Keep on ice 
 
Additional Info: 
All 3 isotopes run until study is over 
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FAME STUDY BLOOD COLLECTION SHEET:  ACETATE 
IRB# 980276  The Effects of Exercise Training on Skeletal Muscle FFA Utilization During 
Exercise in the Elderly 
Investigators:  Bret Goodpaster, PhD (PI)  ph: 692-2437  pg: 958-6186 
  David E. Kelley, MD   ph: 692-2158  pg: 958-5200 
  Silva Arslanian, MD   ph: 692-5174 
  Fernando Boada, PhD   ph: 647-9712 
  Carena Winters-Hart, MS  ph: 692-2158  pg: 958-7925 
                         (coordinator) 
Subject Name_______________________  Date_______ 
Subject ID_______________ Visit #_____ 
Height____________cm Weight____________kg BSA____________m2
Heart Rate (rest)____________ Blood Pressure (rest)  ________________ 
 
*Acetate infusate 1 ml ALIQUOT saved?__________ 
Acetate infusion of ____________________________ 
  started @   ___________stopped @ ___________total vol infused__________ml 
 
*Make Draw-off Tubes for 13C Acetate. 
 
EXERCISE 
         Watts 
H2CO2 Bolus _______     15 min 
        30 min 
        45 min 
        60 min 
 
Acetate Start:  ____________ 
Bike Start:       ____________    VO2max=_________l/min 
              50%=__________l/min 
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BLOOD COLLECTION SHEET   ID#_____________      Visit #____ 
 
Sample Time 
Due 
Time 
Drawn 
Acetate BreathX2 Plasma 
glucose/lactate 
Volume/ 
Tube 
  (1) 5ml 
purple 
(2) 10ml 
red 
0.3 ml 
micro-tube 
Background 
0     Exercise begins.  PI to administer H2CO3 bolus/ start acetate infusion 
15EX      
30EX      
45EX      
60EX      
 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
Signature__________________________Initials________ 
 
 
Background Blood Draw Instructions 
 
After PI ok’s Abg draw two 5 ml purple tops (as baseline for acetate) Keep on ice 
 
Additional Info: 
 
Acetate isotope runs until study is over 
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